Fresenius Medical Care North America

Medical Literature Bibliography 2005 – 2016

Includes work done from the FMCNA patient database over the past decade and work performed by FMCNA-affiliated authors since 2005

2016

1. BACHAR M, RAIMANN JG, KOTANKO P. Impulsive mathematical modeling of ascorbic acid metabolism in healthy subjects.. J Theor Biol. 2016 Mar 7;392:35-47. doi: 10.1016/j.jtbi.2015.11.030. Epub 2015 Dec 24.

2. BONAN NB, STEINER TM, KUNTSEVICH V, VIRZÌ GM, AZEVEDO M, NAKAO LS, BARRETO FC, RONCO C, THIJSSEN S, KOTANKO P, PECOITS-FILHO R, MORENO-AMARAL AN. Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia. Blood Purif. 2016;41(4):317-23. doi: 10.1159/000443784. Epub 2016 Feb 6.

3. BRUNELLI SM, WILSON SM, FICOCIELLO LH, MULLON C, DIAZ-BUXO JA. A Comparison of Clinical Parameters and Outcomes over 1 Year in Home Hemodialysis Patients Using 2008K@home or NxStage System One.. ASAIO J. 2016 Mar-Apr;62(2):182-9. doi: 10.1097/MAT.0000000000000315.

4. CAMPOS, I., CHAN, L., ZHANG, H., DEZIEL, S., VAUGHN, C., MEYRING-WOSTEN, A. AND KOTANKO, P. Intradialytic hypoxemia in chronic hemodialysis patients. Blood Purif. 2016;41(1-3):177-87. doi: 10.1159/000441271. Epub 2016 Jan 15.

5. DE LOS REYES V AA, FUERTINGER DH, KAPPEL F, MEYRING-WÖSTEN A, THIJSSEN S, KOTANKO P. A physiologically based model of vascular refilling during ultrafiltration in hemodialysis. J Theor Biol. 2016 Feb 7;390:146-55. doi: 10.1016/j.jtbi.2015.11.012. Epub 2015 Nov 28.

6. DEKKER MJ, MARCELLI D, CANAUD B, KONINGS CJ, LEUNISSEN KM, LEVIN NW, CARIONI P, MAHESHWARI V, RAIMANN JG, VAN DER SANDE FM, USVYAT LA, KOTANKO P, KOOMAN JP. Unraveling the relationship between mortality, hyponatremia, inflammation and malnutrition in hemodialysis patients: results from the international MONDO initiative. Eur J Clin Nutr. 2016 Apr 20. doi: 10.1038/ejcn.2016.49. [Epub ahead of print]

7. FERRIS M, GIBSON K, PLATTNER B, GIPSON DS, KOTANKO P, MARCELLI D, MARELLI C, ETTER M, CARIONI P, VON GERSDORFF G, XU X, KOOMAN JP, XIAO Q, VAN DER SANDE FM, POWER A, PICOITS-FILHO R, SYLVESTRE L, WESTREICH K, USVYAT L. Hemodialysis outcomes in a global sample of children and young adult hemodialysis patients: the PICCOLO MONDO cohort. Clin Kidney J. 2016 Apr;9(2):295-302. doi: 10.1093/ckj/sfv157. Epub 2016 Mar 5.

8. FISHBANE S, HAZZAN AD, JHAVERI KD, MA L, LACSON E JR. Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2016 Mar 29. pii: CJN.09280915. [Epub ahead of print]

9. HAN M, WILLIAMS S, MENDOZA M, YE X, ZHANG H, CALICE-SILVA V, THIJSSEN S, KOTANKO P, MEYRING-WÖSTEN A. Quantifying Physical Activity Levels and Sleep in Hemodialysis Patients Using a Commercially Available Activity Tracker. Blood Purif. 2016 Jan 15;41(1-3):194-204.

10. KOTANKO P, RONCO C. Preface – Advances in CKD 2016 . Blood Purif. 2016;41(1-3):112-3. doi: 10.1159/000441931. Epub 2016 Jan 15.

11. LIEBMAN S, LI NC, LACSON E. Change in quality of life and one-year mortality risk in maintenance dialysis patients. Qual Life Res. 2016 Mar 3. [Epub ahead of print]

12. MADDUX +C3DW, USVYAT LA, DEFALCO D, KOTANKO P, KOOMAN JP, VAN DER SANDE FM, MADDUX FW. Effects of renal care coordinator case management on outcomes in incident dialysis patients. Clin Nephrol. 2016 Mar;85(3):152-8. doi: 10.5414/CN108713.

13. MADDUX FW. Doing More Than Caring About Quality. Semin Dial. 2016 Mar;29(2):119-24. doi: 10.1111/sdi.12471. Epub 2016 Feb 9.

14. MARN PERNAT A, PERŠIČ V, USVYAT L, SAUNDERS L, ROGUS J, MADDUX FW, LACSON E JR, KOTANKO P. Implementation of routine foot check in patients with diabetes on hemodialysis: associations with outcomes. BMJ Open Diabetes Research and Care 2016;4:e000158. doi:10.1136/bmjdrc-2015- 000158

15. MEYRING-WÖSTEN A, ZHANG H, YE X, FUERTINGER DH, CHAN L, KAPPEL F, ARTEMYEV M, GINSBERG N, WANG Y, THIJSSEN S, KOTANKO P. Intradialytic Hypoxemia and Clinical Outcomes in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2016 Mar 2. pii: CJN.08510815. [Epub ahead of print]

16. NIGWEKAR SU, ZHAO S, WENGER J, HYMES JL, MADDUX FW, THADHANI RI, CHAN KE. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. J Am Soc Nephrol. 2016 Apr 14. pii: ASN.2015091065. [Epub ahead of print]

17. OUELLET G, MALHOTRA R, PENNE EL, USVYAT L, LEVIN NW, KOTANKO P. Neutrophil-lymphocyte ratio as a novel predictor of survival in chronic hemodialysis patients. Clinical Nephrology, Vol. 85 – No. 4/2016 (191-198). DOI 10.5414/CN108745

18. RAIMANN JG, CHAN CT, DAUGIRDAS JT, DEPNER T, GOTCH FA, GREENE T, KAYSEN GA, KLIGER AS, KOTANKO P, LARIVE B, LINDSAY R, ROCCO MV, CHERTOW GM, LEVIN NW; FREQUENT HEMODIALYSIS NETWORK (FHN) TRIAL GROUP. The Effect of Increased Frequency of Hemodialysis on Volume-Related Outcomes: A Secondary Analysis of the Frequent Hemodialysis Network Trials. Blood Purif. 2016;41(4):277-86. doi: 10.1159/000441966. Epub 2016 Jan 21.

19. REBECCA ZUMOFF. Fresenius Medical Care North America CMO to head Kidney Care Partners. Nephrology Business Jan 2016

20. RUTKOWSKI B, TAM P, VAN DER SANDE FM, VYCHYTIL A, SCHWENGER V, HIMMELE R, GAULY A. Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients: A Randomized Controlled Trial. Am J Kidney Dis. 2016 May;67(5):753-61. doi: 10.1053/j.ajkd.2015.07.031. Epub 2015 Sep 20.

2015

21. CALICE-SILVA V, HUSSEIN R, YOUSIF D, ZHANG H, USVYAT L, CAMPOS LG, VON GERSDORFF G, SCHALLER M, MARCELLI D, GRASSMAN A, ETTER M, XU X, KOTANKO P, PECOITS-FILHO R. Associations Between Global Population Health Indicators and Dialysis Variables in the Monitoring Dialysis Outcomes (MONDO) Consortium.. Blood Purif. 2015;39(1-3):125-36. doi: 10.1159/000368980. Epub 2015 Jan 20.

22.. MARCELLI D, USVYAT LA, KOTANKO P, BAYH I, CANAUD B, ETTER M, GATTI E, GRASSMANN A, WANG Y, MARELLI C, SCATIZZI L, STOPPER A, VAN DER SANDE FM, KOOMAN J; MONITORING DIALYSIS OUTCOMES (MONDO) CONSORTIUM. Body composition and survival in dialysis patients: Results from an international cohort study. Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1192-200. doi: 10.2215/CJN.08550814. Epub 2015 Apr 21.

23. BALTER P, FICOCIELLO LH, TAYLOR PB, USVYAT L, SAWIN DA, MULLON C, DIAZ-BUXO J, ZABETAKIS P. A year-long quality improvement project on fluid management using blood volume monitoring during hemodialysis. Curr Med Res Opin. 2015;31(7):1323-31. doi: 10.1185/03007995.2015.1047746. Epub 2015 Jun 3.

24. RAIMANN JG, CANAUD B, ETTER M, KOOMAN JP, LEVIN NW, MARCELLI D, MARELLI C, POWER A, DUNCAN N, VAN DER SANDE FM, CARIONI P, THIJSSEN S, XU X, USVYAT LA, WANG Y, KOTANKO P. Association between pre hemodialysis serum sodium concentration and blood pressure: results from a retrospective analysis from the international monitoring dialysis outcomes (MONDO) initiative. J Hum Hypertens. 2015 Jul 30. doi: 10.1038/jhh.2015.79.

25. THIJSSEN S, WONG MM, USVYAT LA, XIAO Q, KOTANKO P, MADDUX FW. Nutritional Competence and Resilience among Hemodialysis Patients in the Settings of Dialysis Initiation and Hospitalization. Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1593-601. doi: 10.2215/CJN.08430814. Epub 2015 Jul 16.

26. MALHOTRA R1, MARCELLI D, VON GERSDORFF G, GRASSMANN A, SCHALLER M, BAYH I, SCATIZZI L, ETTER M, GUINSBURG A, BARTH C, MARELLI C, CARIONI P, VAN DER SANDE F, KOOMAN JP, LIU E, TOFFELMIRE T, WANG Y, THIJSSEN S, USVYAT LA, KOTANKO P. Relationship of Neutrophil-to-Lymphocyte Ratio and Serum Albumin Levels with C-Reactive Protein in Hemodialysis Patients: Results from 2 International Cohort Studies.. Nephron. 2015 Jul 15. [Epub ahead of print]

27. GUINSBURG AM, USVYAT LA, ETTER M, XU X, THIJSSEN S, MARCELLI D, CANAUD B, MARELLI C, BARTH C, WANG Y, CARIONI P, VAN DER SANDE FM, KOTANKO P, KOOMAN JP; MONITORING DIALYSIS OUTCOMES (MONDO) CONSORTIUM. Seasonal variations in mortality and clinical indicators in international hemodialysis populations from the MONDO registry. BMC Nephrol. 2015 Aug 14;16:139. doi: 10.1186/s12882-015-0129-y.

28. HINDERLITER A, PADILLA RL, GILLESPIE BW, LEVIN NW, KOTANKO P, KISER M, FINKELSTEIN F, RAJAGOPALAN S, SARAN R. Association of carotid intima-media thickness with cardiovascular risk factors and patient outcomes in advanced chronic kidney disease: the RRI-CKD study.. Clin Nephrol. 2015 Jul;84(1):10-20. doi: 10.5414/CN108494.

29. KRISHNAN M, WEINHANDL ED, JACKSON S, GILBERTSON DT, LACSON E JR. Comorbidity Ascertainment From the ESRD Medical Evidence Report and Medicare Claims Around Dialysis Initiation: A Comparison Using US Renal Data System Data. Am J Kidney Dis. 2015 Nov;66(5):802-12. doi: 10.1053/j.ajkd.2015.04.015. Epub 2015 May 23.

30. CHAN KE, EDELMAN ER, WENGER JB, THADHANI RI, MADDUX FW. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.. Circulation. 2015 Mar 17;131(11):972-9. doi: 10.1161/CIRCULATIONAHA.114.014113. Epub 2015 Jan 16.

31. LACSON E JR. Decreasing Exposure to Hemodialysis Catheters in ESRD-More Work to Be Done.. Am J Kidney Dis. 2015 Jun;65(6):820-2. doi: 10.1053/j.ajkd.2015.03.002. No abstract Available.

32.. CHAN KE, NEWTON-CHEH C, GUSELLA JF, MADDUX FW. Heritability of Risk for Sudden Cardiac Arrest in ESRD. . J Am Soc Nephrol. 2015 Apr 16. pii: ASN.2014090881. [Epub ahead of print]

33. PROVENZANO R, HYMES JL. Introduction: Role of the medical director series. Clin J Am Soc Nephrol. 2015 Feb 6;10(2):325. doi: 10.2215/CJN.11811214. Epub 2015 Jan 12. No abstract available.

34. CHERTOW GM1, LEVIN NW2, BECK GJ3, DAUGIRDAS JT4, EGGERS PW5, KLIGER AS6, LARIVE B3, ROCCO MV7, GREENE T8; FREQUENT HEMODIALYSIS NETWORK (FHN) TRIALS GROUP. Long-Term Effects of Frequent In-Center Hemodialysis.. J Am Soc Nephrol. 2015 Oct 14. pii: ASN.2015040426.

35. BROERS NJ1, USVYAT LA, KOOMAN JP, VAN DER SANDE FM, LACSON E JR, KOTANKO P, MADDUX FW. Quality of Life in Dialysis Patients: A Retrospective Cohort Study.. Nephron. 2015;130(2):105-12. doi: 10.1159/000430814. Epub 2015 May 29.

36. WEINHANDL E, CONSTANTINI E, EVERSON S, GILBERTSON D, LI S, SOLID C, ANGER M, BHAT JG, DEOREO P, KRISHNAN M, NISSENSON A, JOHNSON D, IKIZLER TA, MADDUX F, SADLER J, TYSHLER L, PARKER T 3RD, SCHILLER B, SMITH B, LINDENFELD S, COLLINS AJ. Peer Kidney Care Initiative 2014 Report: Dialysis Care and Outcomes in the US. Am J Kidney Dis. 2015 Jun;65(6 Suppl 1):Svi, S1-140. doi: 10.1053/j.ajkd.2015.03.021.

37. MADDUX FW1, NISSENSON AR2. The evolving role of the medical director of a dialysis facility.. Clin J Am Soc Nephrol. 2015 Feb 6;10(2):326-30. doi: 10.2215/CJN.04920514. Epub 2014 Oct 2.

38. LACSON E JR, WANG W, MA L, PASSLICK-DEETJEN J. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study. Am J Kidney Dis. 2015 Dec;66(6):1056-66. doi: 10.1053/j.ajkd.2015.06.014. Epub 2015 Jul 17.

39. FERRARIO M, RAIMANN JG, LARIVE B, PIERRATOS A, THIJSSEN S, RAJAGOPALAN S, GREENE T, CERUTTI S, BECK G, CHAN C, KOTANKO P; FREQUENT HEMODIALYSIS NETWORK (FHN) TRIAL GROUP. Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients.. Blood Purif. 2015;40(1):99-108. doi: 10.1159/000381665. Epub 2015 Jul 4.

40. WILLIAMS ME, MITTMAN N, MA L, BRENNAN JI, MOONEY A, JOHNSON CD, JANI CM, MADDUX FW, LACSON E JR. The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients.. Hemodial Int. 2015 Oct;19(4):562-71. doi: 10.1111/hdi.12312. Epub 2015 May 12.

41. TAO X1, THIJSSEN S, LEVIN N, KOTANKO P, HANDELMAN G. Enhanced Indoxyl Sulfate Dialyzer Clearance with the Use of Binding Competitors.. Blood Purif. 2015;39(4):323-30. doi: 10.1159/000381008. Epub 2015 May 14.

42. HAN SW1, TILEA A, GILLESPIE BW, FINKELSTEIN FO, KISER MA, EISELE G, KOTANKO P, LEVIN N, SARAN R. Serum sodium levels and patient outcomes in an ambulatory clinic-based chronic kidney disease cohort.. Am J Nephrol. 2015;41(3):200-9. doi: 10.1159/000381193. Epub 2015 Apr 8.

43. ROSALES L1, THIJSSEN S, KRUSE A, SIPAHIOGLU MH, HIRACHAN P, RAIMANN JG, KUNTSEVICH V, CARTER M, LEVIN NW, KOTANKO P. Inflammatory Response to Sorbent Hemodialysis.. ASAIO J. 2015 Jul-Aug;61(4):463-7. doi: 10.1097/MAT.0000000000000212.

44. XUE H, LI NC, LACSON E JR, BRUNELLI SM, LOCKRIDGE RS. Catheter-related bacteremia and mortality in frequent nocturnal home hemodialysis. Hemodial Int. 2015 Apr;19(2):242-8. doi: 10.1111/hdi.12245. Epub 2015 Feb 3.

45. MADDUX FW, NISSENSON AR,. The Evolving role of the Medical Director of a Dialysis Facility. Clin J Am Soc Nephrol. 2015 CJN.04920514.

46. REESE DJ, BUILA S, COX S, DAVIS J, OLSEN M, JURKOWSKI E. University-Community-Hospice Partnership to Address Organizational Barriers to Cultural Competence. Am J Hosp Palliat Care. 2015 Sep 23. pii: 1049909115607295. [Epub ahead of print]

47. DIAZ-BUXO JA, ZELLER-KNUTH CE, RAMBARAN KA, HIMMELE R. Home hemodialysis dose: balancing patient needs and preferences. Blood Purif. 2015;39(1-3):45-9. doi: 10.1159/000368944. Epub 2015 Jan 20.

2014

48. 3. 2014 JG, ABBAS SR, LIU L, ZHU F, LARIVE B, KOTANKO P, LEVIN NW, KAYSEN GA. Agreement of single- and multi-frequency bioimpedance measurements in hemodialysis patients: an ancillary study of the frequent hemodialysis network daily trial.. Nephron Clin Pract. 2014;128(1-2):115-26. doi: 10.1159/000366447. Epub 2014 Nov 7.

49. ABBAS SR, LIU L, SIPAHIOGLU MH, ROSALES L, CARTER M, KOTANKO P, LEVIN NW, ZHU F. Comparison of Bioimpedance Techniques to Detect Changes in Fluid Status in Hemodialysis Patients... Blood Purif. 2014;37(1):48-56.

50. ABBAS SR, ZHU F, KAYSEN GA, KOTANKO P, LEVIN NW:. Effect of changes in fluid distribution in body segments in hemodialysis patients at different ultrafiltration rates on accuracy of whole body bioimpedance measurement. J Appl Physiol 2014 (revised).

51. ALEX ROSENBLUM, BSN, RN, WEILING WANG, MS, LYNDA K. Hemodialysis Catheter Care Strategies: A Cluster-Randomized Quality Improvement Initiative. Am J Kidney Dis. 2014;63(2):259-267

52. BENNETT CL, JACOB S, HYMES J, USVYAT LA, MADDUX FW. Anaphylaxis and hypotension after administration of peginesatide. N Engl J Med. 2014 May 22;370(21):2055-6. doi: 10.1056/NEJMc1400883. No abstract available.

53.. BROERS NJ, USVYAT LA, MARCELLI D, BAYH I, SCATIZZI L, CANAUD B, VAN DER SANDE FM, KOTANKO P, MOISSL U, KOOMAN JP. Season affects body composition and estimation of fluid overload in haemodialysis patients: variations in body composition; a survey from the European MONDO database.. Nephrol Dial Transplant. 2014 Dec 9. pii: gfu367. [Epub ahead of print]

54. CHAN CT, CHERTOW GM, DAUGIRDAS JT, GREENE TH, KOTANKO P, LARIVE B, PIERRATOS A, STOKES JB. Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial. Frequent Hemodialysis Network Daily Trial Group.. Nephrol Dial Transplant. 2014 Jan;29(1):168-78. doi: 0.1093/ndt/gft212. Epub 2013 Sep 26.

55. CHANDRA P, SANDS RL, GILLESPIE BW, LEVIN NW, KOTANKO P, KISER M, FINKELSTEIN F, HINDERLITER A, RAJAGOPALAN S, SENGSTOCK D, SARAN R. Relationship between heart rate variability and pulse wave velocity and their association with patient outcomes in chronic kidney disease.. Clin Nephrol. 2014 Jan;81(1):9-19.

56. CORNELIS T, USVYAT LA, TORDOIR JH, WANG Y, WONG M, LEUNISSEN KM, VAN DER SANDE FM, KOTANKO P, KOOMAN JP. Vascular access vulnerability in intensive hemodialysis: a significant Achilles' heel?. Blood Purif. 2014;37(3):222-8. doi: 10.1159/000362106. Epub 2014 Jun 5. Review.

57. DAHLMANN A, DÖRFELT K, EICHER F, LINZ P, KOPP C, MÖSSINGER I, HORN S, BÜSCHGES-SERAPHIN B, WABEL P, HAMMON M, CAVALLARO A, ECKARDT KU, KOTANKO P, LEVIN NW, JOHANNES B, UDER M, LUFT FC, MÜLLER DN, TITZE JM. Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients. . Kidney Int. 2014 Aug 6. doi: 10.1038/ki.2014.269. [Epub ahead of print]

58. DANIEL E. WEINER, MD, MS,1,2 STEVEN M. BRUNELLI, MD, MSCE,3 ABIGAIL HUNT, PHD,3 BRIGITTE SCHILLER, MD, RICHARD GLASSROCK MD, FRANK W. Improving Clinical Outcomes Among Hemodialysis Patients: A Proposal for a "Volume First" Approach From the Chief Medical Officers of US Dialysis Providers. Am J Kidney Dis. 2014;64(5):685-695

59. DEREBAIL VK, LACSON EK JR, KSHIRSAGAR AV, KEY NS, HOGAN SL, HAKIM RM, MOONEY A, JANI CM, JOHNSON C, HU Y, FALK RJ, LAZARUS JM. Sickle trait in african-american hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol. 2014 Apr;25(4):819-26. doi: 10.1681/ASN.2013060575. Epub 2014 Jan 23.

60. DIAZ-BUXO JA. The road to automated peritoneal dialysis: a personal reflection. Artif Organs. 2014 Dec;38(12):993-7. doi: 10.1111/aor.12435. No abstract available.

61. DITTRICH M, SNEJDROVA E. Cyclic swelling as a phenomenon inherent to biodegradable polyesters.. J Pharm Sci. 2014 Nov;103(11):3560-6. doi: 10.1002/jps.24146. Epub 2014 Sep 19.

62. FLYTHE JE, LI NC, LIN SF, BRUNELLI SM, HYMES J, LACSON E JR. Associates of cardiopulmonary arrest in the perihemodialytic period.. Int J Nephrol. 2014;2014:961978. doi: 10.1155/2014/961978. Epub 2014 Nov 4.

63. GERO D.VON GERSDORFF, LEN USVYAT, DANIELE MARCELLI, AILEEN GRASSMANN, CRISTINA MARELLI, MICHAEL ETTER, JEROEN P. KOOMAN, ALBERT POWER, TED TOFFELMIRE, YOSEF S. HAVIV, MATHIAS SCHALLER, INGA BAYH, LAURA SCATIZZI, ADAM TASHMAN, STEPHAN THIJSSEN, NATHAN W. Monitoring dialysis outcomes across the world - the MONDO global database consortium,. Blood Purif. 2014

64. JOSEPH PULLIAM, MD,1 NIEN-CHEN LI, MPH, MSC,1 FRANKLIN MADDUX, MD,1 RAYMOND HAKIM, FREDERIC O FINKLESTEIN, EDUARDO LACSON. First-Year Outcomes of Incident Peritoneal Dialysis Patients in the US. Am J Kidney Dis. 64(5):761-769. ª 2014 by the National Kidney Foundation, Inc.

65. KETCHERSID T. Health information technology: help or hindrance?. Adv Chronic Kidney Dis. 2014 Jul;21(4):365-70. doi: 10.1053/j.ackd.2014.02.014.

66. KEVIN E. CHAN,*† RAVI I. THADHANI,† AND FRANKLIN W. Adherence Barriers to Chronic Dialysis in the United States,. JASN 10.1681/ASN.2013111160

67. KOCYIGIT I, SIPAHIOGLU MH, ORSCELIK O, UNAL A, CELIK A, ABBAS SR, ZHU F, TOKGOZ B, DOGAN A, OYMAK O, KOTANKO P, LEVIN NW. THE ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND FLUID STATUS IN PERITONEAL DIALYSIS PATIENTS.. Perit Dial Int. 2014 Jan 2

68. KOOMAN JP, KOTANKO P, SCHOLS AM, SHIELS PG, STENVINKEL P. Chronic kidney disease and premature ageing.. Nat Rev Nephrol. 2014 Dec;10(12):732-42. doi: 10.1038/nrneph.2014.185. Epub 2014 Oct 7

69. KOTANKO P, KOOMAN J, VAN DER SANDE F, KAPPEL F, USVYAT L. Accelerated or out of control; the final months on dialysis. Ren Nutr. 2014 Nov;24(6):357-63. doi: 10.1053/j.jrn.2014.06.011. Epub 2014 Sep 3.

70. KUHTIN O, SCHMIDT-ROHLFING B, DITTRICH M, LAMPL L, HOHLS M, HAAS V. Treatment Strategies for Septic Arthritis of the Sternoclavicular Joint.]. Zentralbl Chir. 2014 Nov 13. [Epub ahead of print] German.

71. LACSON E JR, BRUCE L, LI NC, MOONEY A, MADDUX FW. Depressive affect and hospitalization risk in incident hemodialysis patientsClin. J Am Soc Nephrol. 2014 Oct 7;9(10):1713-9. doi: 10.2215/CJN.01340214. Epub 2014 Oct 2

72. MAHESH KRISHNAN,* STEVEN M. BRUNELLI,* FRANKLIN W. MADDUX,† THOMAS F. Guiding Principals and Checkists for Population-Based Quality Measures. CJASN ePress. Published on February 20, 2014 as doi: 10.2215/CJN.11061013

73. RAIMANN JG, KIRISITS W, GEBETSROITHER E, CARTER M, CALLEGARI J, ROSALES L, LEVIN NW, KOTANKO P. Saliva urea dipstick test: application in chronic kidney disease.. Clin Nephrol. 2014 Dec;82(12):358-66. doi: 10.5414/CN108370.

74. SANDS JJ, USVYAT LA, SULLIVAN T, SEGAL JH, ZABETAKIS P, KOTANKO P, MADDUX FW, DIAZ-BUXO JA. Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome.. Hemodial Int. 2014 Jan 27.

75. TAO X, HOENICH N, HANDELMAN SK, LEVIN NW, KOTANKO P, HANDELMAN GJ. Transfer of low-molecular weight single-stranded DNA through the membrane of a high-flux dialyzer.. Int J Artif Organs. 2014 Jul 31;37(7):529-38. doi: 10.5301/ijao.5000338. Epub 2014 Jul 21

76. WILLIAMS ME, GARG R, WANG W, LACSON R, MADDUX F, LACSON E JR,. High Hemoglobin A1c levels and glycemic variability increase risk of severe hypoglycemia in diabetic hemodialysis patients. Hemodial Int. 2014 Apr;18(2):423-32. doi: 10.1111/hdi.12110

77. ZHU F, KAYSEN GA, SARKAR S, FINKELSTEIN F, CARTER M, SERGEYEVA O, GOTCH F, LEVIN NW, HOENICH N. Evaluation of effects of one year frequent dialysis on fluid loading using calf normalized resistivity. ASAIO J 2014 (Second revised).

2013 78. ASCI G., TÖZ H., OZKAHYA M., DUMAN S., DEMIRCI M.S., CIRIT M., SIPAHI S.,

DHEIR H., BOZKURT D., KIRCELLI F., OK E.S., ERTEN S., ERTILAV M., KOSE T., BASCI A., RAIMANN J.G., LEVIN N.W. The Impact of Membrane Permeability and Dialysate Purity on Cardiovascular Outcomes.Ok E. and the EGE Study Group.. JASN 2013, 24(6): 1014-23.

79. CALLEGARI J, ANTWI S, WYSTRYCHOWSKI G, ZUKOWSKA-SZCZECHOWSKA E, LEVIN NW, CARTER M. Peritoneal dialysis as a mode of treatment for acute kidney injury in sub-saharan Africa. Blood Purif. 2013;36(3-4):226-30.

80. CHAN CT, COVIC A, CRAIG JC, DAVENPORT A, KASISKE BL, KUHLMANN MK, LEVIN NW, LI PK, LOCATELLI F, ROCCO MV, WHEELER DC. Novel techniques and innovation in blood purification: a clinical update from Kidney Disease: Improving Global Outcomes.. Kidney Int. 2013 Jan 16.

81. CHAN CT, GREENE T, CHERTOW GM, KLIGER AS, STOKES JB, BECK GJ, DAUGIRDAS JT, KOTANKO P, LARIVE B, LEVIN NW, MEHTA RL, ROCCO M, SANZ J, YANG PC, RAJAGOPALAN S; THE FREQUENT HEMODIALYSIS NETWORK TRIAL GROUP. Effects of Frequent Hemodialysis on Ventricular Volumes and Left Ventricular Remodeling. Clin J Am Soc Nephrol. 2013 Aug 22.

82. CHAZOT C, OK E, LACSON E JR, KERR PG, JEAN G, MISRA M. Thrice-weekly nocturnal hemodialysis: the overlooked alternative to improve patient outcomes. Nephrol Dial Transplant. 2013 Apr 17. [Epub ahead of print]

83. D.H. FUERTINGER, F. KAPPEL. A parameter identification technique for structured population equationsmodeling erythropoiesis in dialysis patients. Proceedings of the World Congress on Engineering and Computer Science 2013, WCECS 2013, 23-25 October, San Francisco, USA, 2013.

84. D.H. FUERTINGER, F. KAPPEL, S. THIJSSEN, N.W. LEVIN, AND P. KOTANKO. A numerical method for structured population equations modeling control of erythropoiesis. Proceedings of the 1st IFAC Workshop on the Control of Systems Modeled by Partial Differential Equations (CPDE 2013), September 25-27, Paris (France), A model of er. Journal of Mathematical Biology, 66(6): 1209-1240, 2013.

85. DE SOUZA CM, BRAOSI AP, LUCZYSZYN SM, OLANDOSKI M, KOTANKO P, CRAIG RG, TREVILATTO PC, PECOITS-FILHO R. Association Between Oral Health Parameters, Periodontitis and its Treatment and Mortality in Hemodialysis Patients.. J Periodontol. 2013 Nov 14.

86. EDUARDO LACSON JR, MD, MPH, FRANKLIN MADDUX. Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber meets the road. Am J Kidney Dis. 2013;62(5):874-876

87. EVAN R. Electronic Communication and Text Messaging Among Nephrology Providers. Am J Kidney Dis. 2013;62(4):656-658

88. FISHBANE S, SCHILLER B, LOCATELLI F, COVIC AC, PROVENZANO R, WIECEK A, LEVIN NW, KAPLAN M, MACDOUGALL IC, FRANCISCO C, MAYO MR, POLU KR, DULIEGE AM, BESARAB A; EMERALD STUDY GROUPS. Peginesatide in patients with anemia undergoing hemodialysis.. N Engl J Med. 2013 Jan 24;368(4):307-19.

89. GARRY HANDELMAN, PETER KOTANKO, M CISTERNAS, NICHOLAS HOENICH, LEN USVYAT, MARTIN HUHLMANN, NATHAN LEVIN:. Hospitalization and Mortality in Hemodialysis Patients: Association with Hemoglobin Variability,. Blood Purif. 2013 May 8;35(4):247-257

90. GOTCH F, KOTANKO P, LEVIN N. How can we improve the solute and fluid transport prescriptions in hemodialysis to improve patient outcomes?. Blood Purif. 2013;35(1-3):93-105

91. HECKING M, KARABOYAS A, ANTLANGER M, SARAN R, WIZEMANN V, CHAZOT C, RAYNER H, HÖRL WH, PISONI RL, ROBINSON BM, SUNDER-PLASSMANN G, MOISSL U, KOTANKO P, LEVIN NW, SÄEMANN MD, KALANTAR-ZADEH K, PORT FK, WABEL P. Significance of Interdialytic Weight Gain versus Chronic Volume Overload: Consensus Opinion.. Am J Nephrol. 2013;38(1):78-90.

92. HUE XUE, JOACHIM H IX, STEVEN M BRUNELLI, EDUARDO LACSON. In Reply to ‘Thrombolytic Protocol Potentially Reduces Catheter-Related Complications in Hemodialysis Patients'. Am J Kidney Dis. 2013;62(3):642-645

93. JEROEN KOOMAN, NATASHA BROERS, LEN USVYAT, STEPHAN THIJSSEN, FRANK VAN DER SANDE, TOM CORNELIS, NATHAN LEVIN, KAREL LEUNISSEN, PETER KOTANKO:. Out of control: accelerated aging in uremia,. Nephrol Dial Transplant. 2013 Jan;28(1):48-54

94. JOHANNA KUIPERS, LEN USVYAT, J OOSTERHUIS , J DASSELAAR, P DE JONG, R WESTERHUIS, JEFF SANDS, YUEDONG WANG, PETER KOTANKO, CASPER FRANSSEN:. Variability of Predialytic, Intradialytic, and Postdialytic Blood Pressures in the Course of a Week: A Study of Dutchand US Maintenance Hemodialysis Patients. Am J Kidney Dis. 2013 Jun 4

95. JONES JP, LEONARD EF, SANDHU G, WINKEL G, LEVIN NW, CORTELL S. Daily Ultrafiltration Results in Improved Blood Pressure Control and More Efficient Removal of Small Molecules during Hemodialysis. Blood Purif. 2013 Jan 8;34(3-4):325-331.

96. JOSE A. DIAZ-BUXO,* SARAH A. Frequent Hemodialysis: A Critical Review. Seminars in Dialysis—2013

97. KETCHERSID T. Big data in nephrology: friend or foe?. Blood Purif. 2013;36(3-4):160-4. doi: 10.1159/000356751. Epub 2013 Dec 20.

98. KEVIN E. CHAN1,2, RAVI I. THADHANI2 AND FRANKLIN W. No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease. Kidney International 2013

99.. KIDNEY INT 2013, 83(5): 949-58. DAUGIRDAS J.T., GREENE T., KAYSEN G.A., DEPNER T.A., LEVIN N.W., CHERTOW G.M., ORNT D.B., RAIMANN J.G., LARIVE B. Effect of frequent hemodialysis on residual kidney function.. Kliger A.S. and the FHN Trial Group.

100. LACSON E JR, MADDUX FW, HAKIM RM. In reply to 'A more cautious stance on nutritional supplementation for hypoalbuminemia is justified' and 'intradialytic oral nutritional supplements improve quality of life'. AJKD 2013

101. LACSON E, MADDUX FW. Intensity of the quality of care and better outcomes among hemodialysis patients: A role for the Medical Director. Seminars in Dialysis 2012;25:299-302

102. LEN USVYAT, CLAUDIA BARTH, INGA BAYH, MICHAEL ETTER, GERO VON GERSDORFF, AILEEN GRASSMANN, ADRIAN GUINSBURG, MAGGIE LAM, DANIELE MARCELLI, CRISTINA MARELLI, LAURA SCATIZZI, MATHIAS SCHALLER, ADAM TASHMAN, TED TOFFELMIRE, STEPHAN THIJSSEN, YUEDONG WANG, JE. Dynamics of interdialytic weight gain, systolic blood pressure, and serum albumin levels in chronic dialysis patients before death,. Kidney Int. 2013 Jul;84(1):149-57

103. LEN USVYAT, JEROEN KOOMAN, FRANK VAN DER SANDE, YUEDONG WANG, FRANKLIN W MADDUX, NATHAN W LEVIN, PETER KOTANKO:. Dynamics of hospitalizations in hemodialysis patients: results from a large US provider. Nephrol Dial Transplant. 2013 Jun 11

104. LEN USVYAT, YOSEF HAVIV, MICHAEL ETTER, JEROEN KOOMAN, DANIELE MARCELLI, CRISTINA MARELLI, ALBERT POWER, TED TOFFELMIRE, YUEDONG WANG, PETER KOTANKO:. The MONitoring Dialysis Outcomes (MONDO) initiative,. Blood Purif. 2013;35(1-3):37-48

105. LYNDA K. Fatal Vascular Access Hemorrhage: Reducing the Odds. Nephrology Nursing

106. MADDUX FW, MCMURRAY S, NISSENSON AR. Toward population management in an integrated care model., . Clin J Am Soc Nephrol. 2013 Apr;8(4):694-700. doi: 10.2215/CJN.09050912. Epub 2013 Mar 28

107. MOLFINO A, HEYMSFIELD SB, ZHU F, KOTANKO P, LEVIN NW, DWYER T, KAYSEN GA. Prealbumin is Associated With Visceral Fat Mass in Patients Receiving Hemodialysis. J Ren Nutr. 2013 Apr 24.

108. MOLLICONE D, PULLIAM J, LACSON JR E. The Culture of Education in a Large Dialysis Organization: Informing Patient-Centered Decision Making on Treatment Options for Renal Replacement Therapy., . Semin Dial. 2013 Feb 14. doi: 10.1111/sdi.12053. [Epub ahead of print]

109. MOSKOWITZ JL, PIRET SE, LHOTTA K, KITZLER TM, TASHMAN AP, VELEZ E, THAKKER RV, KOTANKO P. Association between genotype and phenotype in uromodulin-associated kidney disease.. Clin J Am Soc Nephrol. 2013 Aug;8(8):1349-57.

110. NETWORK (FHN) TRIALS. ORNT DB, LARIVE B, RASTOGI A, RASHID M, DAUGIRDAS JT, HERNANDEZ A, TAMURA MK, SURI RS, LEVIN NW, KLIGER AS; THE FREQUENT HEMODIALYSIS NETWORK TRIAL GROUP. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis. Nephrol Dial Transplant. 2013 Jan 27.

111.. PARK J, JIN DC, MOLNAR MZ, DUKKIPATI R, KIM YL, JING J, LEVIN NW, NISSENSON AR, LEE JS, KALANTAR-ZADEH K. Mortality Predictability of Body Size and Muscle Mass Surrogates in Asian vs White and African American. Hemodialysis Patients Mayo Clin Proc. 2013 May;88(5):479-86.

112. PARKER TF 3RD, HAKIM R, NISSENSON AR, KRISHNAN M, BOND TC, CHAN K, MADDUX FW, GLASSOCK R. A Quality initiative. Reducing rates of hospitalizations by objectively monitoring volume removal" . Nephrol News Issues 2013 Mar;27(3) 30-2,34-6

113. RAIMANN J.G. AND LEVIN N.W. Pneumatic compression devices to avoid intradialytic morbid events.. Nephrol Dial Transplant 2013, 28(4): 779-81.

114. RAIMANN JG, ZHU F, WANG J, THIJSSEN S, KUHLMANN MK, KOTANKO P, LEVIN NW, KAYSEN GA. Comparison of fluid volume estimates in chronic hemodialysis patients by bioimpedance, direct isotopic, and dilution methods.. Kidney Int. 2013 Sep 25.

115. REYES-BAHAMONDE J, RAIMANN JG, THIJSSEN S, LEVIN NW, KOTANKO P. Fluid overload and inflammation--a vicious cycle.. Semin Dial. 2013 Jan-Feb;26(1):31-5.

116. SAGAR U. NIGWEKAR,*† STEVEN M. BRUNELLI,‡§ DEBRA MEADE,| WEILING WANG,| JEFFREY HYMES,| AND EDUARDO LACSON JR. Sodium Thiosulfate for Calcific Uremic Arteriolopathy. Clin J AM Soc Nephrol 8: 1162-1170 July 2013

117. SEIBERT E, MÜLLER SG, FRIES P, PATTMÖLLER J, KUSS O, HEINE GH, GIRNDT M, SCHNEIDER G, KOTANKO P, ZHU F, LEVIN NW, KUHLMANN MK. Calf bioimpedance spectroscopy for determination of dry weight in hemodialysis patients: effects on hypertension and left ventricular hypertrophy.. Kidney Blood Press Res. 2013;37(1):58-67.

118. SURI RS, LINDSAY RM, BIEBER BA, PISONI RL, GARG AX, AUSTIN PC, MOIST LM, ROBINSON BM, GILLESPIE BW, COUCHOUD C, GALLAND R, LACSON E, ZIMMERMAN DL, LI Y, NESRALLAH GE, FOR THE INTERNATIONAL QUOTIDIAN DIALYSIS REGISTRY INVESTIGATORS. In-center nocturnal dialysis performed thrice-weekly - a provider's perspective.. Kidney International (e-pub Sept.12)

119. THIJSSEN S, KAPPEL F, KOTANKO P. Absolute blood volume in Hemodialysis patients: why is it relevant, and how to measure it?. Blood Purif. 2013;35(1-3):63-71.

120. THIJSSEN S, KOSSMANN RJ, KRUSE A, KOTANKO P. Clinical evaluation of a model for prediction of end-dialysis systemic ionized calcium concentration in citrate hemodialysis.. Blood Purif. 2013;35(1-3):133-8.

121. USVYAT LA, BARTH C, BAYH I, ETTER M, VON GERSDORFF GD, GRASSMANN A, GUINSBURG AM, LAM M, MARCELLI D, MARELLI C, SCATIZZI L, SCHALLER M, TASHMAN A, TOFFELMIRE T, THIJSSEN S, KOOMAN JP, VAN DER SANDE FM, LEVIN NW, WANG Y, KOTANKO P. Interdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to death. Kidney Int. 2013 Jul;84(1):149-57.

122. WILLIAMS C, RONCO C, KOTANKO P. Whole grains in the renal diet--is it time to reevaluate their role?. Blood Purif. 2013;36(3-4):210-4.

123. ZHU F, KAPPEL F, LEONARD EF KOTANKO P, LEVIN NW. Modeling of Change in Blood Volume and Extracellular Fluid Volume during Hemodialysis.. Conf Proc IEEE Eng Med Biol Soc. 2013 July;1506-1509, 2013

2012

124. 2012 DOU Y, ZHU F, KOTANKO P. Assessment of Extracellular Fluid Volume and Fluid Status in Hemodialysis Patients: Current Status and Technical. Advance Seminars in Dialysis 377-387

125. ALLEN R. NISSENSON, MD,1 FRANKLIN W. MADDUX, MD,2 RUBEN L. VELEZ, MD,3 TRACY J. Accountable Care Organizations and ESRD: The Time Has Come. Am J Kidney Dis. 2012;59(5):724-733

126. AXLEY B, ROSENBLUM A. Learning why patients with central venous catheters resist permanent access placement, . Nephrol Nurs J. 2012 Mar-Apr;39(2):99-103; quiz 104

127. CALLEGARI JG, KILONZO KG, YEATES KE, HANDELMAN GJ, FINKELSTEIN FO, KOTANKO P, LEVIN NW, CARTER M. KIDNEY INT. 2012 FEB;81(4):331-3. KOTANKO P, LEVIN NW, RONCO C. PREFACE. Peritoneal dialysis for acute kidney injury in sub-Saharan Africa: challenges faced and lessons learned at Kilimanjaro Christian Medical Centre.. Blood Purif. 2012 Jan 20;33(1-3):105-106.

128. CARTER M, KILONZO K, ODIIT A, KALYESUBULA R, KOTANKO P, LEVIN NW, CALLEGARI J. Acute Peritoneal Dialysis Treatment Programs for Countries of the East African Community.. Blood Purif. 2012 Jan 20;33(1-3):149-152

129. CHAN CT, GREENE T, CHERTOW GM, KLIGER AS, STOKES JB, BECK GJ, DAUGIRDAS JT,KOTANKO P, LARIVE B, LEVIN N, MEHTA RL, ROCCO M, SANZ J, SCHILLER B, YANG PC,RAJAGOPALAN S. Determinants of Left Ventricular Mass in Patients on Hemodialysis: The Frequent Hemodialysis Network (FHN) Trials.. Circ Cardiovasc Imaging. 2012 Feb 23.

130. CHAN KE, WARREN HS, THADHANI RI, STEELE DJ, HYMES JL, MADDUX FW, HAKIM RM. Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD. J Am Soc Nephrol. 2012 23:1551-9.

131. CHANDRA P, SANDS RL, GILLESPIE BW, LEVIN NW, KOTANKO P, KISER M, FINKELSTEIN F, HINDERLITER A, POP-BUSUI R, RAJAGOPALAN S, SARAN R. Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant. 2012 Feb;27(2):700-9. doi: 10.1093/ndt/gfr340. Epub 2011 Sep 12.

132. CORNELIS T, KOTANKO P, GOFFIN E, VAN DER SANDE FM, KOOMAN JP, CHAN CT. Intensive hemodialysis in the (nursing) home: the bright side of geriatric ESRD care?. Semin Dial. 2012 Nov-Dec;25(6):605-10.

133. CRAIG RG, PERNAT AM, PECOITS-FILHO R, LEVIN NW, KOTANKO P. Periodontal Diseases and Systemic Inflammation.. Semin Dial. 2012 Oct 9.

134. DOU Y, KRUSE A, KOTANKO P, ROSEN H, LEVIN NW, THIJSSEN. Red blood cell life span and 'erythropoietin resistance' S.. Kidney Int. 2012 Jun;81(12):1275-6

135. DROOG RP, KINGMA BR, VAN MARKEN LICHTENBELT WD, KOOMAN JP, VAN DER SANDE FM, LEVIN NW, VAN STEENHOVEN AA, FRIJNS AJ. Mathematical Modeling of Thermal and Circulatory Effects During Hemodialysis.. Artif Organs. 2012 Jul 2.

136. E, LHOTTAA K, PIRETE S, KRAMARC R, THAKKER R, SUNDER-PLASSMANND G, KOTANKO P. Epidemiology of Uromodulin-Associated Kidney Disease – Results from a Nation-Wide Survey. Nephron Extra 2012;2:147-158

137. EDUARDO LACSON JR. Depressive symptoms associate with high mortality risk and dialysis withdrawal in incident hemodialysis patients. Nephrol Dial Transplant (2012) 0: 1–8

138. EDUARDO LACSON JR, FRANKLIN W. Intensity of Care adn better Outcomes among Hemodialysis Patients: A Role of the Medical Director. Seminars in dialysis 2012 May;59(5):724-33

139. EDUARDO LACSON JR, MD, MPH, WEILING WANG, MS BARBARA ZEBROWSKI, REBECCA WINGARD, RAYMOND M HAKIM. Outcomes Associated With Intradialytic Oral Nutritional Supplements in Patients Undergoing Maintenance Hemodialysis: A Quality Improvement Project. Am J Kidney Dis. 2012;60(4):591-600

140.. ERIC SEIBERT1,3, FANSAN ZHU1,2, MARTIN K. KUHLMANN1,4, RUTH HENSON1, ADRIAN M. Slope analysis of blood volume and calf bioimpedance monitoring in hemodialysis patients. Nephrol Dial Transplant (2012) 27: 4430–4436

141. FLYTHE J, LACSON E. Outcomes after the long interdialytic break: Implications for the dialytic prescriptions,. Seminars in Dialysis; 25: 1-8, 2012

142. HALL YN, LARIVE B, PAINTER P, KAYSEN GA, LINDSAY RM, NISSENSON AR, UNRUH ML,ROCCO MV, CHERTOW GM;. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials.. Clin J Am Soc Nephrol. 2012 May;7(5):782-94.

143. HANRAHAN CT, HIMMELE R, DIAZ-BUXO JA. The challenges of heat sterilization of peritoneal dialysis solutions: is there an alternative?, . Adv Perit Dial. 2012;28:126-30

144. HIMMELE R, JENSEN L, FENN D, HO CH, SAWIN DA, DIAZ-BUXO JA. A new neutral-pH low-GDP peritoneal dialysis fluid. Perit Dial Int. 2012 Jul-Aug;32(4):444-52. doi: 10.3747/pdi.2011.00072. Epub 2012 Mar 1

145. HIMMELE R, SAWIN DA, DIAZ-BUXO JA. GDPs and AGEs: impact on cardiovascular toxicity in dialysis patients.. Adv Perit Dial. 2011;27:22-6. Review.

146. HUI XUE, MD, MMSC,1 JOACHIM H. Hemodialysis Access Usage Patterns in the Incident Dialysis Year and Associated Catheter-Related Complications. Am J Kidney Dis. 61(1):123-130. © 2012 by the National Kidney Foundation, Inc.

147. JEFFREY J. SANDS A PETER KOTANKO B, C JONATHAN H. Effects of Citrate Acid Concentrate (Citrasate ) on Heparin N requirement and hemodialysis adequacy. Blood Purif 2012;33:199–204

148. JOCHEN G. RAIMANN,* NATHAN W. LEVIN,* RONALD G. Is Vitamin C Intake Too Low in Dialysis Patients. Seminars in Dialysis—Vol 26, No 1 (January–February) 2013

149. JOHN J ROGUS1,2*, SHU-FANG LIN1 AND EDUARDO K LACSON JR1. Efficient Monte Carlo Resampling of Continuous Data with a Dichotomous. ISSN:2155-6180 JBMBS, an open access journal

150. KAYSEN GA, GREENE T, LARIVE B, MEHTA RL, LINDSAY RM, DEPNER TA, HALL YN, DAUGIRDAS JT, CHERTOW GM; FHN TRIAL GROUP. The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial... Kidney Int. 2012 Jul;82(1):90-9.

151. KETCHERSID T. Lessons learned: the CMS incentive programs for EHRs,. Nephrol News Issues. 2012 Mar;26(3):30, 32-3. No abstract available.

152. KILONZO KG, GHOSH S, TEMU SA, MARO V, CALLEGARI J, CARTER M, HANDELMAN G,FINKELSTEIN FO, LEVIN N, YEATES K. Outcome of acute peritoneal dialysis in northern Tanzania.. Perit Dial Int. 2012 May;32(3):261-6.

153. KIRSCH S, THIJSSEN S, ALARCON SALVADOR S, HEINE GH, VAN BENTUM K, FLISER D, SESTER M, SESTER U. T-cell numbers and antigen-specific T-cell function follow different circadian rhythms.. Clin Immunol. 2012 Dec;32(6):1381-9.

154. KITZLER TM, JABERI A, SENDLHOFER G, REHAK P, BINDER C, PETNEHAZY E, STACHER R, KOTANKO P. Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial.. Wien Klin Wochenschr. 2012 May;124(9-10):312-319

155. KOOMAN JP, USVYAT L, VAN DER SANDE FM, THIJSSEN S, LEVIN N, LEUNISSEN KM, KOTANKO P. Time and Time Again': Oscillatory and Longitudinal Time Patterns in Dialysis Patients.. Kidney Blood Press Res. 2012 Aug 8;35(6):534-548

156. KOTANKO P, LEVIN NW, RONCO C. . 14th International Conference on Dialysis, Advances in Chronic Kidney Disease 2012. Preface.. Blood Purif. 2012;33(1-3):105-6

157. KRISHNAN M, WILFEHRT HM, LACSON E. In data we trust: The role and utility of dialysis provider databases in the policy process. Clin J Am Soc Nephrol. 2012 Nov;7(11):1891-6. doi: 10.2215/CJN.03220312. Epub 2012 Sep 13

158.. LACSON E, WANG W, ZEBROWSKI B, WINGARD R, HAKIM RM, MADDUX FW. Monitored intradialytic oral nutritional supplements and hospital risk in chronic hemodialysis. Proceedings of the XVI ICRNM Congress; 2012 Jun 25-29; Honolulu, HI, USA. Bologna, Italy: Medimond S.R.L. 2012.

159. LACSON E, XU J, SURI RS, NESRALLAH G, LINDSAY R, GARG AX, LESTER K, OFSTHUN N, LAZARUS J, HAKIM RM. Survival with three-times weekly in-center nocturnal versus conventional hemodialysis.. Journal of the American Society of Nephrology; 23(4):687-95, 2012

160. LEN A. USVYAT, JOCHEN G. RAIMANN, STEPHAN THIJSSEN, PETER KOTANKO, NATHAN W. Absolute Changes in Systolic Blood Pressure Relate to Mortality: Results of an Observational Cohort Study in Incident Hemodialysis Patients. Blood Purif 2012;33:120–126

161. LEN USVYAT, JOCHEN RAIMANN, PETER KOTANKO, NATHAN W. Impacts of blood pressure patterns of patient outcomes,. Kidney Int. 2012 Mar;81(6):548-58

162. LEN USVYAT, MARY CARTER, STEPHAN THIJSSEN, JEROEN P. KOOMAN, FRANK M. Seasonal variations in mortality and treatment parameters in dialysis patients: a five year cohort study,. Clin J Am Soc Nephrol. 2012 Jan;7(1):108-15

163. LEN USVYAT, PETER KOTANKO, FRANK M. VAN DER SANDE, JEROEN P. KOOMAN, MARY CARTER, KAREL ML. LEUNISSEN, NATHAN W. Circadian Variations Affect The Rise In Body Temperature During Dialysis,. Nephrol Dial Transplant. 2012 Mar;27(3):1139-44.

164. LIU L, ZHU F, G RAIMANN J, THIJSSEN S, SIPAHIOGLU MH, WYSTRYCHOWSKI G, KITZLERT, TETTA C, WABEL P, KOTANKO P, LEVIN NW. Determination of fluid status in haemodialysis patients with whole body and calf bioimpedance techniques.. Nephrology (Carlton). 2012 Feb;17(2):131-40.

165. MADDUX DW, WEST C. The benefits of exercise for CKD patients.. Nephrol News Issues. 2012 Nov;26(12):44, 46, 48.

166. MADDUX FW. Impact of the bundled end-stage renal disease payment system on patient care.. Blood Purif. 2012;33(1-3):107-11.

167. MADDUX, FW. Inpact of the bundled end-stage renal disease payment system on patient care. Blood Purif. 2012;33(1-3)

168. MORA-BRAVO F.G., DE-LA-CRUZ G., RIVERA S., MARISCAL-RAMIREZ A., RAIMANN J.G. Association of intradialytic hypotension and convective volume in hemodiafiltration: results from a retrospective study. BMC Nephrology 2012, 13(1):106.

169. MURAT SIPAHIOGLU, LEN USVYAT, LI LIU, SAMER ABBAS, JOCHEN RAIMANN, LAURA ROSALES, NATHAN LEVIN, PETER KOTANKO:. Early systolic blood pressure changes in incident hemodialysis patients are associated with mortality in the first year,. Kidney Blood Press Res. 2012;35(6):663-70

170. NESRALLAH GE, LINDSAY RM, CUERDEN MS, GARG AX, PORT F, AUSTIN PC, MOIST LM, PIERRATOS A, CHAN CT, ZIMMERMAN D, LOCKRIDGE RS, COUCHOUD C, CHAZOT C, OFSTHUN N, LEVIN A,. Copland hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol. 2012 Apr;23(4):696-705. doi: 10.1681/ASN.2011070676. Epub 2012 Feb 21

171. NESRALLAH GE, LINDSAY RM, CUERDEN MS, GARG AX, PORT F, AUSTIN PC, MOIST LM, PIERRATOS A, CHAN CT, ZIMMERMAN D, LOCKRIDGE RS, COUCHOUD C, CHAZOT C, OFSTHUN N, LEVIN A, COPLAND M, COURTNEY M, STEELE A, MCFARLANE PA, GEARY DF, PAULY RP, KOMENDA P, SURI RS. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol. 2012 Apr;23(4):696-705. doi: 10.1681/ASN.2011070676. Epub 2012 Feb 2

172. RAIMANN J.G., USVYAT L.A., THIJSSEN S., KOTANKO P., ROGUS J., LACSON E., LEVIN N.W. Blood pressure stability in hemodialysis patients confers a survival advantage: results from a large retrospective cohort study. Kidney Int. 2012, 81(6): 548-58.

173. RAIMANN JG, KITZLER TM, LEVIN NW. Factors Affecting Loss of Residual Renal Function(s) in Dialysis.. Contrib Nephrol. 2012;178:150-6.

174. RAIMANN JG, KRUSE A, THIJSSEN S, KUNTSEVICH V, DABEL P, BACHAR M, DIAZ-BUXO JA, LEVIN NW, KOTANKO P. Metabolic effects of dialyzate glucose in chronic hemodialysis: results from a prospective, randomized crossover trial.. Nephrol Dial Transplant. 2012 Apr;27(4):1559-68.

175. RITA S. SURI1, ROBERT M. LINDSAY1, BRIAN A. BIEBER2, RONALD L. PISONI2, AMIT X. GARG1,3,4, PETER C. A multinational cohort study of in-center daily. Kidney International (2013) 83, 300–307

176. SERGEYEVA O., GORODETSKAYA I., RAMOS R., SCHILLER B.M., LARIVE B., RAIMANN J.G., TING G.O., EGGERS P.W., CHERTOW G.M., LEVIN N.W. AND THE FHN TRIAL GROUP. Challenges to Enrollment and Randomization of the Frequent Hemodialysis Network (FHN) Daily Trial.. J Nephrol 2012, 25(3): 302-9.

177. STEPHAN THIJSSEN, LEN USVYAT, PETER KOTANKO:. Prediction of Mortality in the First Two Years of Hemodialysis: Results from a Validation Study.. Blood Purif 2012;33:80–85

178. SURI RS, LINDSAY RM, BIEBER BA, PISONI RL, GARG AX, AUSTIN PC, MOIST LM, ROBINSON BM, GILLESPIE BW, COUCHOUD C, GALLAND R, LACSON E, ZIMMERMAN DL, LI Y, NESRALLAH GE, FOR THE INTERNATIONAL QUOTIDIAN DIALYSIS REGISTRY INVESTIGATORS. In-center nocturnal dialysis performed thrice-weekly - a provider's perspective., . Kidney International (e-pub Sept.12)

179. USVYAT LA, CARTER M, THIJSSEN S, KOOMAN JP, VAN DER SANDE FM, ZABETAKIS P, BALTER P, LEVIN NW, KOTANKO P. Seasonal variations in mortality, clinical, and laboratory parameters in hemodialysis patients: a 5-year cohort study. Clin J Am Soc Nephrol. 2012 Jan;7(1):108-15. doi: 10.2215/CJN.03880411. Epub 2011 Nov 17

180. USVYAT LA, RAIMANN JG, CARTER M, VAN DER SANDE FM, KOOMAN JP, KOTANKO P, LEVIN NW. Relation between trends in body temperature and outcome in incident hemodialysis patients., . Nephrol Dial Transplant. 2012 Aug;27(8):3255-63. doi: 10.1093/ndt/gfr808. Epub 2012 May 7.

181. WINGARD RL, CHAN KE, HAKIM R. RightReturn. Partnering to reduce the high rate of hospital readmission for dialysis-dependent patients. Nephrol News Issues. 2012 26:20-2.

182. WINGARD RL, WHITE C, ROSENBLUM A. The medical director's role in improving outcomes: a nursing perspective.. Semin Dial. 2012 May;25(3):293-6. doi: 10.1111/j.1525-139X.2012.01076.x. Epub 2012 Apr 12. Review. No abstract available

183. ZHU F, KOTANKO P, THIJSSEN S, LEVIN NW CONF PROC IEEE. Prediction of intradialytic morbid events in hemodialysis patients by monitoring the second derivative of relative blood volume. Eng Med Biol Soc. 2012;2012:1226-9.

2011

184. , KAYSEN GA, KOTANKO P, ZHU F, SARKAR SR, HEYMSFIELD SB, KUHLMANN MK, DWYER T, USVYAT L, HAVEL P, LEVIN NW. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr. 2009 Sep;19(5):357-64. doi: 10.1053/j.jrn.2009.04.002. Epub 2009 Jul 10.

185. ALLON M, DINWIDDLE L, LACSON E, LATOS DL, LOK CE, STEINMAN T, WEINER DE. Medicare reimbursement policies and hemodialysis vascular access outcomes: A need for change.. Journal of the American Society of Nephrology; 22: 426-430, 2011

186. AMANDA K. STENNETT, NORMA J. OFSTHUN, AND FRANK A. Application of Kinetic Modeling to Mineral Metabolism. Seminars in Dialysis—Vol 24, No 5 (September–October)

187. BRENER ZZ, THIJSSEN S, KOTANKO P, KUHLMANN MK, BERGMAN M, WINCHESTER JF,LEVIN NW. The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients.. Blood Purif. 2011;31(4):243-51.

188. CHAN KE, PFLEDERER TA, STEELE DJR, LILLY MP, IKIZLER T, MADDUX FW, HAKIM RM. Access Survival amongst Hemodialysis Patients Referred for Preventive Angiography and Percutaneous transluminal Angioplasty. CJASN 2011 NOv;6(11):2669-80

189. CHAN, KE, MADDUX FW, TOLKOFF-RUBIN N, THADHANI R, HAKIM, RM. Early Outcomes among Those Initiating Chronic Dialysis In the US. CJASN 2011 NOv;6(11)

190. CHANDRA P, SANDS RL, GILLESPIE BW, LEVIN NW, KOTANKO P, KISER M, FINKELSTEIN F, HINDERLITER A, POP-BUSUI R, RAJAGOPALAN S, SARAN R. Predictors of heart rate variability and its prognostic significance in chronic kidney disease.. Nephrol Dial Transplant. 2011 Sep 12.

191. CNOSSEN TT, USVYAT L, KOTANKO P, VAN DER SANDE FM, KOOMAN JP, CARTER M, LEUNISSEN KM, LEVIN NW. Comparison of outcomes on continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis: results from a USA database.. Perit Dial Int. 2011 Nov;31(6):679-84

192. CORNELIS T, KOTANKO P, GOFFIN E, KOOMAN JP, VAN DER SANDE FM, CHAN CT. Can Intensive hemodialysis prevent loss of functionality in the elderly ESRD patient?. Semin Dial. 2011 Nov;24(6):645-52.

193. DAUGIRDAS JT, GREENE T, DEPNER TA, LEVIN NW, CHERTOW GM. Modeled urea distribution volume and mortality in the HEMO Study.. Clin J Am Soc Nephrol. 2011 May;6(5):1129-38.

194. DIAZ-BUXO JA, KOTANKO P. Introduction to Pharmatech. Semin Dial. 2011 Sep-Oct;24(5):578-9.

195. EDUARDO LACSON JR, MD, MPH, WEILING WANG, MS, CARI DEVRIES, KEITH LESTE, MA, RAYMOND M HAKIM, MICHAEL LAZARUS, JOSEPH PULLIAM. Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access and Patient Outcomes. Am J Kidney Dis. 58(2):235-242. © 2011 by the National Kidney Foundation, Inc.

196. FERRARIO M, RAIMANN JG, THIJSSEN S, SIGNORINI MG, KRUSE A, DIAZ-BUXO JA, CERUTTI S, LEVIN NW, KOTANKO P. Effects of dialysate glucose concentration on heart rate variability in chronic hemodialysis patients: results of a prospective randomized trial.. Kidney Blood Press Res. 2011;34(5):334-43.

197. FINKELSTEIN FO, JUERGENSEN P, WANG S, SANTACROCE S, LEVINE M, KOTANKO P, LEVIN NW, HANDELMAN GJ. Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis. Perit Dial Int. 2011 Jan-Feb;31(1):74-9

198. HYMES J1, BICKIMER T, JACKSON JH, BOOKHART BK, MODY SH, TAK PIECH C. Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa.. Curr Med Res Opin. 2007 Aug;23(8):1931-7.

199. KAYSEN GA, LARIVE B, PAINTER P, CRAIG A, LINDSAY RM, ROCCO MV, DAUGIRDAS JT, SCHULMAN G, CHERTOW GM; FHN TRIAL GROUP. Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.. Am J Kidney Dis. 2011 Jan;57(1):101-12

200. KETCHERSID T. Meaningful use: where do we go from here?, . Nephrol News Issues. 2011 Dec;25(13):30, 32. No abstract available.

201. KEVIN E. CHAN1, T. ALP IKIZLER2, JORGE L. GAMBOA3, CHANG YU4, RAYMOND M. HAKIM1 AND NANCY J. Combined angiotensin-converting enzyme inhibition and receptor blockage associate with increased risk of cardiovascular death in hemodialysis patients. Kidney International (2011) 80, 978–985

202. KOLB J, KITZLER TM, TAUBER T, MORRIS N, SKRABAL F, KOTANKO P. Proto-dialytic cardiac function relates to intra-dialytic morbid events.. Nephrol Dial Transplant. 2011 May;26(5):1645-51

203. KOTANKO P, LEVIN NW, RONCO C. Preface. A new era in dialysis reimbursement. Blood Purif. 2011;31(1-3):59-60. doi: 10.1159/000322925. Epub 2011 Jan 10. No abstract available

204. KRUSE A, TAO X, BHALANI V, HANDELMAN G, LEVIN NW, KOTANKO P, THIJSSEN S. Clearance of p-cresol sulfate and β-2-microglobulin from dialysate by commercially available sorbent technology.. ASAIO J. 2011 May-Jun;57(3):219-24

205. LACSON E. Epidemiology of hemodialysis vascular access in the United States. Clinical Nephrology; 75: 497-505, 2011

206. LACSON E. Fresenius expanding INHD program. Nephrol News Issues; 25(8): 29-31, 2011

207. LACSON E, BRUNELLI SM. Hemodialysis treatment time: A fresh perspective. CJASN; 6: 2225-2230, 2011 Oct

208. LACSON E, DIAZ-BUXO, J. In-center nocturnal hemodialysis performed thrice-weekly – A provider’s perspective.,. Seminars in Dialysis; 24: 668 – 673, 2011

209. LACSON E, HAKIM RM. The 2011 ESRD prospective payment system: Perspectives from Fresenius Medical Care, a large dialysis organization.. American Journal of Kidney Diseases; 57: 547-549, 2011

210. LACSON E, LAZARUS JM. Dialysis time: Does it matter? A reappraisal of existing literature., . Current Opinions in Nephrology and Hypertension; 20: 189-194, 2011

211. LACSON E, WANG W, MOONEY A, OFSTHUN N, LAZARUS JM, HAKIM RM. Abandoning peracetic acid-based dialyzer reuse is associated with improved survival.. CJASN, 6: 297-302, 2011

212. LATIF W, KARABOYAS A, TONG L, WINCHESTER JF, ARRINGTON CJ, PISONI RL, MARSHALL MR, KLEOPHAS W, LEVIN NW, SEN A, ROBINSON BM, SARAN R. Uric Acid levels and all-cause and cardiovascular mortality in the hemodialysis population.. Clin J Am Soc Nephrol. 2011 Oct;6(10):2470-7

213. LEN A. USVYAT; JOCHEN G. RAIMANN, MD; MARY CARTER, PHD; FRANK M. VAN DER SANDE, MD, PHD; JEROEN P. KOOMAN, MD, PHD; PETER KOTANKO, MD; NATHAN W. Relation between trends in body temperature and outcome in incident hemodialysis patients.. Nephrol Dial Transplant. 2011

214. LEVIN NW, RAIMANN JG, ROCCO MV. . Should the knowledge gained from the Frequent Hemodialysis Network (FHN) trials change dialysis practice?. Curr Opin Nephrol Hypertens. 2011 Nov;20(6):577-82

215. LINDSAY RM, SURI RS, MOIST LM, GARG AX, CUERDEN M, LANGFORD S, HAKIM R, OFSTHUN NJ, MCDONALD SP, HAWLEY C, CASKEY FJ, COUCHOUD C, AWARAJI C, NESRALLAH GE. International quotidian dialysis registry: Annual report 2010. Annual report 2010.Hemodial Int. 2011 Jan 14. doi: 10.1111/j.1542-4758.2010.00521.x. [Epub ahead of print]

216. LIU L, ZHU F, RAIMANN J, SIPAHIOGLU MH, WYSTRYCHOWSKI G, KITZLER T, THIJSSEN S, TETTA C, WABEL P, KOTANKO P, LEVIN NW. Determination of hydration status in hemodialysis patients with whole body and calf bioimpedance techniques. Nephrology (Carlton). 2011 Sep 27.

217. METRY G, ADHIKARLA R, SCHNEDITZ D, RONCO C, LEVIN NW. Effect of changes in the intravascular volume during hemodialysis on blood viscoelasticity.. Indian J Nephrol. 2011 Apr;21(2):95-100.

218. PASCHKE E, FAULER G, WINKLER H, SCHLAGENHAUF A, PLECKO B, ERWA W, BREUNIG F, URBAN W, VUJKOVAC B, SUNDER-PLASSMANN G, KOTANKO P. Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study.. Am J Kidney Dis. 2011 May;57(5):673-81. E

219. PETER KOTANKO, NATHAN W. Preface: RRI 13th International Conference. Blood Purif 2011;31:59–60

220. PIRET SE, DANOY P, DAHAN K, REED AA, PRYCE K, WONG W, TORRES RJ, PUIG JG, MÜLLER T, KOTANKO P, LHOTTA K, DEVUYST O, BROWN MA, THAKKER RV. Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome.. 2p22.1-p21. Hum Genet. 2011 Jan;129(1):51-8

221. QUNIBI W, WINKELMAYER WC, SOLOMON R, MOUSTAFA M, KESSLER P, HO CH, GREENBERG J, DIAZ-BUXO JA. A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease., . BMC Nephrol. 2011 Feb 16;12:9. doi: 10.1186/1471-2369-12-9

222. RAIMANN JG, THIJSSEN S, LEVIN NW. A brief review of external mass balance and internal calcium redistribution in dialysis patients-is calcium a uremic toxin?. J Ren Nutr. 2012 Jan;22(1):186-90

223. RAIMANN JG, THIJSSEN S, RAMOS R, LEVIN NW. More frequent hemodialysis: what do we know? Where do we stand?. Contrib Nephrol. 2011;171:10-6

224. RAIMANN JG, THIJSSEN S, USVYAT LA, LEVIN NW, KOTANKO P. Sodium alignment in clinical practice--implementation and implications.. Semin Dial. 2011 Sep-Oct;24(5):587-92. doi: 10.1111/j.1525-139X.2011.00973.x.

225. ROCCO MV, LARIVE B, EGGERS PW, BECK GJ, CHERTOW GM, LEVIN NW, KLIGER AS; FHN TRIAL GROUP. Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.. Am J Kidney Dis. 2011 Jan;57(1):90-100

226. ROCCO MV, LOCKRIDGE RS JR, BECK GJ, ET AL. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.. Kidney Int. 2011 Nov;80(10):1080-91. doi: 10.1038/ki.2011.213.

227. ROSENBLUM A, MOLLICONE D, WINGARD R, LACSON E. Getting patients and renal staff to embrace “Fistula First/Catheter Last”., . Nephrol News Issues; 25(9): 26-30, 2011

228. SANDS JJ, DIAZ-BUXO JA. Improving the delivery of coordinated and individualized care,. Semin Dial. 2011 Sep-Oct;24(5):593-6. doi: 10.1111/j.1525-139X.2011.00974.x.

229. SAUER PF, FARRELL RE, LAZARUS JM. The ESRD demonstration project: what it accomplished Fresenius Medical Care FMCNA. Nephrol News Issues. 2011 Jun;25(7):32, 34-5, 37-8. No abstract available

230. THAKURIA M, OFSTHUN NJ, MULLON C, DIAZ-BUXO JA. Anemia management in patients receiving chronic hemodialysis., . Semin Dial. 2011 Sep-Oct;24(5):597-602. Doi 0.1111/j.1525-139X 4.

231. THIJSSEN S, RAIMANN JG, USVYAT LA, LEVIN NW, KOTANKO P. The evils of intradialytic sodium loading.. Contrib Nephrol. 2011;171:84-91.

232.. USVYAT LA, KOTANKO P, VAN DER SANDE FM, KOOMAN JP, CARTER M, LEUNISSEN KM, LEVIN NW. Circadian variations in body temperature during dialysis. Nephrol Dial Transplant. 2011 Jul 19 0: 1–6

233. ZHU F, KOTANKO P, HANDELMAN GJ, RAIMANN JG, LIU L, CARTER M, KUHLMANN MK, SEIBERT E, LEONARD EF, LEVIN NW. Estimation of normal hydration in dialysis patients using whole body and calf bioimpedance analysis.. Physiol Meas. 2011 Jul;32(7):887-902.

2010

234. BRENER ZZ. KOTANKO P, THIJSSEN S, WINCHESTER JF, BERGMAN M. Clinical Benefit of Preserving Residual Renal Function in Dialysis Patients: An Update for Clinicians.. Am J Med Sci. 2010 May; 339 (5): 453-6.

235. C. Calcium Balance in Dialysis is Best managed by Adjusting Dialysate Calcium Guided by Kinetic Modeling of the Interrelationship Between Calcium Intake, Dose of Vitamin D Analogues and the Dialysate Calcium Concentration. Blood Purif. 2010; 29 (2): 163-76.

236. CAVANAUGH KL, WINGARD RL, HAKIM RM, EDEN S, SHINTANI A, WALLSTON KA, HUIZINGA MM, ELASY TA, ROTHMAN RL, IKIZLER TA. Low Health Literacy Associates with Increased Mortality in ESRD. J Am Soc Nephrol. 2010 Jul 29. [Epub ahead of print]

237. CHAN CT, LEVIN NW, CHERTOW GM, LARIVE B, SCHULMAN G, KOTANKO P;. Determinants of cardiac autonomic dysfunction in ESRD.. Clin J Am Soc Nephrol. 2010 Oct;5(10):1821-7.

238. CHAN KE, THADHANI R, LAZARUS JM, HAKIM RM. Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes. Clin J Am Soc Nephrol. 2010 May;5(5):856-66. Epub 2010 Mar 25.

239. CHERTOW GM, LEVIN NW, BECK GJ, DEPNER TA, EGGERS PW, GASSMAN JJ, GORODETSKAYA I, GREENE T, JAMES S, LARIVE B, LINDSAY RM, MEHTA RL, MILLER B, ORNT DB, RAJAGOPALAN S, RASTOGI A, ROCCO MV, SCHILLER B, SERGEYEVA O, SCHULMAN G,TING GO, UNRUH ML, STAR RA, KLI. In-center hemodialysis six times per week versus three times per week. FHN Trial Group,. N Engl J Med. 2010 Dec 9;363(24):2287-300.

240. DAUGIRADAS JT, DEPNER TA, GREENE T, LEVIN NW, CHERTOW GM, ROCCO MV,. Standard Kt/Vurea: A Method of Calculation That Includes Effects of Fluid Removal and Residual Kidney Clearance.. Frequent Hemodialysis Network Trial Group Kidney Int. 2010 Apr: 77 (7): 637-44.

241. DAUGIRDAS JT, DEPNER TA, GREENE T, LEVIN NW, CHERTOW GM, ROCCO MV, STOKES JB; FREQUENT HEMODIAYSIS NETWORK (FHN) TRIAL GROUP. Effects of Reduced Intradialytic Urea Generation Rate and Residual Renal Clearance on Modeled Urea Distribution Volume and Kt/V in Conventional, Daily, and Nocturnal Dialysis.. Semin Dial. 2010 Jan; 23 (1): 19-24.

242. DIAZ-BUXO J, CLARK SC, HO CH, JENSEN LE. New pH-neutral peritoneal dialysis solution, low in glucose degradation products, in a double-chamber bag. Adv Perit Dial. 2010;26:28-32

243. DIAZ-BUXO JA, HIMMELE R. Strategies to universally improve peritonitis rates, including use of dialysis solutions with low glucose degradation products. Adv Perit Dial. 2010;26:37-40.

244.. EDUARDO LACSON, JR., WEILING WANG, J. MICHAEL LAZARUS, AND RAYMOND M. Change in Vascular Access and Hospitalization Risk in Long-Term Hemodialysis Patients. Clin J Am Soc Nephrol 5: 1996–2003, 2010. doi: 10.2215/CJN.08961209

245. FRANKLIN MADDUX, KEVIN CHAN, CRISTINA GUZMAN, DEBORAH REGIDOR, DUGAN MADDUX,. A Retrospective cohort study of trends in Hemoglobin levels erythropoieses-stimulating agent treated chronic kidney disease non dialysis patients in the Fresenius Medical Care NA CKD registry. NKF 2010 Spring Clinical Meetings Abstracts

246. GEORG FLEISCHMANN1, GUNDULA FILLAFER1, HEIKE MATTERER1, FALKO SKRABAL1 AND PETER KOTANKO. Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrol Dial Transplant (2010) 25: 181–186

247. GOTCH FA, KOTANKO P, THIJSSEN S, LEVIN NW. The KDIGO Guideline for Dialysate Calcium Will Result in an Increased Incidence of Calcium Accumulation in Hemodialysis Patients.. Kidney Int. 2010 Jun 2.

248. KEVIN E. CHAN,*† J. MICHAEL LAZARUS,* AND RAYMOND M. Digoxin Associates with Mortality in ESRD. JASN 21: 1550–1559, 2010. doi: 10.1681/ASN.2009101047

249. KEVIN E. CHAN,*† RAVI THADHANI,† J. MICHAEL LAZARUS,* AND RAYMOND M. Modeling the 4D Study: Statins and Cardiovascular Outcomes in Long-term Hemodialysis Patients with Diabetes. Clin J Am Soc Nephrol 5: 856–866, 2010. doi: 10.2215/CJN.07161009

250. KORGAONKAR S, TILEA A, GILLESPIE BW, KISER M EISELE G, FINKELSTEIN F, KOTANKO P, PITT B, SARAN R. Serum Potassium and Outcomes in CKD: Insights from the RRI_CKD Cohort Study.. Clin J Am Soc Nephrol. 2010 May; 5 (5): 762-9.

251. KOTANKO P, LEVIN NW, RONCO C. Preface. Advances in Chronick Kidney Disease 2010. Blood Purif, 2010; 29 (2): 79-80.

252. KOTANKO PM, KUHLMANN K, LEVIN NW,. Hemodialysis:Outcomes and Adequacy,. Comprehensive Clinical Nephrology, Chapter 89 p 1053-1059

253. KUHLMANN K, KOTANKO P, LEVIN NW,. Hemodialysis: Principles and Techniques,. Comprehensive Clinical Nephrology, Chapter 90 p 1060-1068

254. LACSON E JR, WANG W, LESTER K, OFSTHUN N, LAZARUS JM, HAKIM RM. Outcomes Associated with In-Center Nocturnal Hemodialysis from a Large Multicenter Program.. Clin J Am Soc Nephrol. 2010 Feb;5(2):220-6. Epub 2009 Dec 3

255. LACSON E JR, XU J, LIN SF, DEAN SG, LAZARUS JM, HAKIM RM. A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Clin J Am Soc Nephrol. 2010 Feb;5(2):252-60. doi: 10.2215/CJN.07231009. Epub 2009 Dec 17.

256. LEVIN NW, KOTANKO P, ECKARDT KU, KASISKE BL, CHAZOT C, CHEUNG AK, REDON J, WHEELER DC, ZOCCALI C, LONDON GM. Blood Pressure in Chronic Kedney Disease Stage 5D-Report from a Kidney Disease: Improving Global Outcomes Controversies Conference.. Kidney Int. 2010 Feb;77(4):273-84.

257. NISSENSON AR, JONES ER, MADDUX FW. Specialist Practices as Medical Homes. n engl j med 363;10 nejm.org september 2, 2010

258. NISSENSON AR, JONES ER, MADDUX FW. Specialist practices as medical homes. N Engl J Med. 2010 Sep 2;363(10):992; author reply 992-3. No abstract available

259. PENNE EL, LEVIN NW, KOTANKO P. Improving volume status by comprehensive dietary and dialytic sodium management in chronic hemodialysis patients.. Blood Purif. 2010;30(1):71-8.

260. PENNE EL, THIJSSEN S, RAIMANN JG, LEVIN NW, KOTANKO P. Correction of Serum Sodium for Glucose Concentration in Hemodialysis Patients with Poor Glucose Control.. Diabetes Care. 2010 Jul: 33 (7): e91.

261. PRAJCZER S, HEIDENREICH U, PFALLER W, KOTANKO P, LHOTTA K, JENNINGS P. Evidence for a Role of Uromodulin in Chronic Kidney Disease Progression.. Nephrol Dial Transplant. 2010 Jun; 25 (6): 1896-903.

262. RAIMANN JG, KRUSE A, THIJSSEN S, KUNTSEVICH V, DIAZ-BUXO JA, LEVIN NW, KOTANKO P. Fatigue in hemodialysis patients with and without diabetes: results from a randomized controlled trial of two glucose-containing dialysates.. Diabetes Care. 2010 Sep;33(9):e121.

263. SENGSTOCK D, SANDS RL, GILLESPIE BW, ZHANG X, KISER M, EISELE G, VAITKEVICIUS P, KUHLMANN M, LEVIN NW, HINDERLITER A, RAJAGOPALAN S, SARAN R. Dominance of Traditional Cardiovascular Risk Factors Over Renal Function in Predicting Arterial Stiffness in Subjects with Chronic Kidney Disease.. Nephrol Dial Transplant. 2010 Mar; 25 (3): 853-61.

264. SKUMAR B, TILEA A, GILLESPIE BW, ZHANG X, KISER M, EISELE G, FINKELSTEIN F, KOTANKO P, LEVIN NW, RAJAGOPALAN S, SARAN R. Significance of Self-reported Sleep Quality (SQ) in Chronic Kidney Disease (CKD): The Renal Research Institute (RRI)-CKD Study.. Clin Nephrol. 2010 Feb; 73 (2): 104-14.

265. STEVEN M. BRUNELLI1,2, GLENN M. CHERTOW3, ELIZABETH D. ANKERS4, EDMUND G. Shorter dialysis times are associated with higher. Kidney International (2010) 77, 630–636

266. THIJSSEN S, KRUSE A, RAIMANN J, BHALANI V, LEVIN NW, KOTANKO P. A Mathematical Model of Regional Citrate Anticoagulation in Hemodialysis.. Blood Purif. 2010; 29 (2): 197-203.

267. TULLIS RH, DUFFIN RP, ICHIM TE, JOYCE JA, LEVIN NW. Modeling Hepatitis C Virus Therapies Combining Drugs and Lectin Affinity Plasmapheresis.. Blood Purif. 2010; 29 (2): 210-5.

268. WILLIAMS ME, LACSON E JR, WANG W, LAZARUS JM, HAKIM R. Glycemic Control and Extended Hemodialysis Survival in Patients with Diabetes Mellitus: Comparative Results of Traditional and Time-Dependent Cox Model Analyses, . Clin J Am Soc Nephrol. 5: 1595-1601, 2010

269. XUE H, LACSON E, WANG W, CURHAN G, BRUNELLI S. Choice of vascular access among incident hemodialysis patients: A decision and cost-utility analysis. CJASN; 5: 2289-2296, 2010, Dec

2009

270. . VAN DER SANDE FM, WYSTRYCHOWSKI G, KOOMAN JP, ROSALES L, RAIMANN J, KOTANKO P, CARTER M, CHAN CT. LEUNISSEN KM, LEVIN NW. Control of Core Temperature and Blood Pressure Stability during Hemodialysis. Clin J Am Soc Nephrol. CJASN January 2009 4): (1) 93-98

271. CARTER M, ZHU F, KOTANKO P, KUHLMANN M, RAMIREZ L, HEYMSFIELD SB, HANDELMAN G, LEVIN NW. Assessment of Body Composition in Dialysis Patients by Arm Bioimpedance Compared to MRI and K Measurements.. Blood Purif. 2009 Mar 9;27(4):330-337.

272. CAVANAUGH KL, WINGARD RL, HAKIM RM, ELASY TA, IKIZLER TA. Patient dialysis knowledge is associated with permanent arteriovenous access use in chronic hemodialysis., Clin J Am Soc Nephrol. 2009 May;4(5):905-6.

273. CHAN KE, LAZARUS JM, THADHANI R, HAKIM RM. Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients., . J Am Soc Nephrol 2009 Apr;20(4):827-81.

274. CHAN KE, LAZARUS JM, THADHANI R, HAKIM RM. Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation. J Am Soc Nephrol. 2009 Oct;20(10):2223-33. Epub 2009 Aug 27.

275. CRAIG RG, KOTANKO P. Periodontitis and the end-stage renal disease patient receiving hemodialysis maintenance therapy., . Compend Contin Educ Dent. 2009 Oct;30(8):544, 546-52. Review.

276. DEROSE SF, RUTKOWSKI MP, LEVIN NW, LIU IL, SHI JM, JACOBSEN SJ, CROOKS PW. Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease.. Kidney Int. 2009 Jun 10.

277. DEUZIMAR KULAWIK,* JEFFREY J. Focused Vascular Access Education to Reduce the Use of Chronic Tunneled Hemodialysis Catheters: Results of a Network Quality Improvement Initiative. Seminars in Dialysis—Vol 22, No 6

278. EDMUND G. Illustrating Use of a Clinical Data System: The NMC-FMC System. Clin J Am Soc Nephrol 4: S41–S48, 2009. doi: 10.2215/CJN.02680409

279. EDUARDO LACSON JR, MD, MPH, WEILING WANG, MS, J. MICHAEL LAZARUS, MD, AND RAYMOND M. Change in Vascular Access and Mortality in Maintenance Hemodialysis Patients. Am J Kidney Dis 54:912-921. © 2009 by the National Kidney Foundation, Inc.

280. FOLEY RN, HAKIM RM. Why is the Mortality of Dialysis Patients in the United States Much Higher than the Rest of the World. J Am Soc Nephrol. 2009 Jul:20(7):1432-5

281. FRANK A. Pro/Con debate: the calculation on calcium balance in dialysis lowers the dialysate calcium concentrations. Nephrol Dial Transplant (2009) 24: 2994–2996

282. FRANKLIN W. MADDUX, TIMOTHY A. Institutional Variability of Intraoperative Red Blood Cell Utilization in Coronary Artery Bypass Graft Surgery. American Journal of Medical Quality 2009 24:403-411

283. GREENE T, DAUGIRDAS JT, DEPNER TA, GOTCH F, KUHLMAN M; FREQUENT HEMODIALYSISNETWORK STUDY GROUP; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEYDISEASES; NATIONAL INSTITUTES OF HEALTH. Solute clearances and fluid removal in the frequent hemodialysis network trials. Am J Kidney Dis. 2009 May;53(5):835-44.Epub 2009 Apr 1

284. HAKIM RM, IKIZLER TA. Anabolic interventions in ESRD: Light at the end of the tunnel?,. Am J Kidney Dis. 2009 Aug; 54(2):201-4

285. KEVIN E. CHAN1, J. MICHAEL LAZARUS1, REBECCA L. WINGARD1 AND RAYMOND M. Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge. Kidney International (2009) 76, 331–341

286. KOTANKO P, THIJSSEN S, USVYAT L, TASHMAN A, KRUSE A, HUBER C AND LEVIN NW: TEMPORAL EVOLUTION OF CLINICAL PARAMETERS BEFORE DEATH IN DIALYSIS PATIENTS: A NEW CONCEPT. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.. Blood Purif 27:38-47.2009

287. KSHIRSAGAR AV, CRAIG RG, MOSS KL, BECK JD, OFFENBACHER S, KOTANKO P, KLEMMER PJ, YOSHINO M, LEVIN NW, YIP JK, ALMAS K, LUPOVICI EM, USVYAT LA, FALK RJ. Periodontal diesease adversely affects the survival of patients with end-stage renal disease.. Kidney Int. 2009 Jan 21

288. LACSON E JR, WANG W, LAZARUS JM, HAKIM RM. Hemodialysis facility-based quality-of-care indicators and facility-specific patient outcomes, . Am J Kidney Dis, 2009 Sept; 54(3):390-7.

289. LACSON E JR, XU J, LIN SF, DEAN SG, LAZARUS JM, HAKIM R. Association between achievement of hemodialysis quality-of-care indicators and quality-of-life scores. Am J Kidney Dis. 2009 Dec;54(6):1098-107. Epub 2009 Sep 25

290. LACSON EJ R, WANG W, HAKIM RM, TENG M, LAZARUS JM. Associates of Mortality and Hospitalization in Hemodialysis: Potentially Actionable Laboratory Variables and Vascular Access. Am J Kidney Dis 2009 Jan; 53(1) 79-90

291. LEVIN NW, KOTANKO, RONCO C. RRI's 11th International Conference on Dialysis, Advances in CKD 2009, emphasized new developments in both technology and process.. Blood Purif. 2009;27(1):5

292. LOWRIE EG. Does a statistical method suggest a new pathobiology for hemodialysis patients?,. J Am Soc Nephrol. 2009 Sep;20(9):1867-9. doi: 10.1681/ASN.2009060649. Epub 2009 Aug 27. No abstract available

293. RAIMANN J, LIU L, TYAGI S, LEVIN NW, KOTANKO P. A fresh look at dry weight.. Hemodial Int. 2008 Oct; 12(4):395-405.

294. RAYMOND M. Hemodialysis access failure: a call to action—revisited. Kidney International (2009) 76, 1040–1048

295. RONALD L. PISONI, PHD,1 CHARLOTTE J. ARRINGTON, MPH,1 JUSTIN M. Facility Hemodialysis Vascular Access Use and Mortality in Countries. Am J Kidney Dis 53:475-491. © 2009 by the National Kidney Foundation, Inc.

296. SANDS JJ. Vascular access: the past, present and future., . Blood Purif. 2009;27(1):22-7. doi: 10.1159/000167004. Epub 2009 Jan 23. Review.

297. SANDS JJ, LACSON E JR, OFSTHUN NJ, KAY JC, DIAZ-BUXO JA. Home hemodialysis: a comparison of in-center and home hemodialysis therapy in a cohort of successful home hemodialysis patients. ASAIO J. 2009 Jul-Aug;55(4):361-8., ASAIO J. 2009 Jul-Aug;55(4):361-8.

298. SUNDELL MB, CAVANAUGH KL, WU P, SHINTANI A, HAKIM RM, IKIZLER TA. Oral Protein Supplementation Alone Improves Anabolism in a Dose-Dependent Manner in Chronic Hemodialysis Patients., . J Ren Nutr, 2009 Sept; 19(5):412-21

299. T KOTANKO P, THIJSSEN S, USVYAT L, TASHMAN A KRUSE A, HUBER C, LEVIN NW. Temporal evolution of clinical parameters before death in dialysis patients: a new concept.. Blood Purif. 2009;27(1):5

300. THIJSSEN S, ZHU F, KOTANKO P, LEVIN NW. Comment on "higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition".. Clin J Am Soc Nephrol. 2009 May;4(5):1011-3

301. VAN DER SANDE FM, WYSTRYCHOWSKI G, KOOMAN JP, ROSALES L, RAIMANN J, KOTANKO P, CARTER M, CHAN CT, LEUNISSEN KM, LEVIN NW. Control of core temperature and blood pressure stability during hemodialysis. Clin J Am Soc Nephrol. 2009 Jan;4(1):93-8. doi: 10.2215/CJN.01800408. Epub 2008 Oct 8.

302. WILLIAMS ME, LACSON E JR, TENG M, HAKIM RM, LAZARUS JM. Extremes of Glycemic Control (HbA(1c)) Increase Hospitalization Risk in Diabetic Hemodialysis Patients in the USA. Am J Nephrol. 2009;29(1):54-61. Epub 2008 Aug 8.

303. WINGARD RL, CHAN KE, LAZARUS JM, HAKIM RM. The "right" of passage: surviving the first year of dialysis. Clin J Am Soc Nephrol. 2009 Dec; 4 Suppl 1:S114-20

304. WYSTRYCHOWSKI G, KITZLER TM, THIJSSEN S, USVYAT L, KOTANKO P AND LEVIN NW:. Impact of switch of vascular access type on key clinical and laboratory parameters in chronic haemodialysis patients. Nephrol Dial Transplant 24:2194-2200.2009

2008

305. ADRIANA HUNG,1,2 LARA PUPIM,2 CHANG YU,3 AYUMI SHINTANI,3 EDWARD SIEW,2 CARLOS AYUS, RAYMOND K HAKIM, TALAT ALP IKISLER. Determinants of c-ractive protein in chronic hemodialysis patients . Hemodialysis International 2008; 12:236–243

306. CHAN KE, LAFAYETTE RA, WHITTEMORE AS, HLATKY MA, MORAN J. Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients. Nephrol Dial Transplant. 2008 Sep;23(9):2948-56. Epub 2008 May 9

307. CHEUNG A., GREENE T. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients.. Clin J Am Soc Nephrol.2008 Jan;3(1):69-77,

308. COSGROVE DO, CHAN KE. Renal transplants: what ultrasound can and cannot do. Ultrasound. Ultrasound Q. 2008 Jun;24(2):77-87; quiz 141-2. Review

309. D. CRONIN-FINE, F. GOTCH, N.W. LEVIN, P.. KOTANKO, M. A mathematical model comparing solute kinetics in low- and high-BMI hemodialysis patients.. Int J Artif Organs. 2007

310. DAUGIRDAS JT, DEPNER TA, GREENE T, KUHLMANN MK, LEVIN NW, CHERTOW GM, ROCCO MV. Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.. Semin Dial. 2008 Sep-Oct;21(5):415-21.

311. DAUGIRDAS JT, LEVIN NW, KOTANKO P, DEPNER TA, KUHLMANN MK, CHERTOW GM, ROCCO MV. Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area.. Semin Dial.2008 Sep-Oct;21(5):377-84

312. DIAZ-BUXO JA. Case report of encapsulating peritoneal sclerosis: the interpretation of functional and structural peritoneal changes. Blood Purif. 2008;26(1):12-7. doi: 10.1159/000110557. Epub 2008 Jan 10. Review.

313. DIAZ-BUXO JA, CRAWFORD-BONADIO T. The continuum home program concept., . Clin Nephrol. 2008 May;69(5):326-30

314. EDMUND G. Prescribing and Monitoring hemodialysis dose. Kidney International (2008) 74, 262–264. doi:10.1038/ki.2008.224

315. FRANKLIN W. The Role of the Medical Director: Changing with the Times. Seminars in dialysis - Vol 21. No. 1 (Jan/Feb) 2008

316. FRANKLIN W MADDUX, DUGAN W MADDUX,. Characterizing the Ideal Clinical Office System for Nephrology. Advances in Chronic Kidney Disease, Volume 15, Issue 1, Pages 64-72

317. HANDELMAN GJ, LEVIN NW. Iron and anemia in human biology: a review of mechanisms.. Heart Fail Rev (2008) 13:393–404

318. HENRIE M, FORD C, ANDERSEN M, STROUP E, DIAZ-BUXO J, MADSEN B, BRITT D, HO CH. In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology, and permeability,. Artif Organs. 2008 Sep;32(9):701-10. doi: 10.1111/j.1525-1594.2008.00592.x. Epub 2008 Jul 30.

319. HIRACHAN P, THIJSSEN S, LEVIN NW, KOTANKO P. Body composition and outcomes in chronic hemodialysis patients.. Contrib Nephrol. 2008;161:108-14

320. HOENICH N, THIJSSEN S,KITZLER T, LEVIN R, RONCO C,. Impact of Water Quality and Dialysis,Fluid Composition on Dialysis Practice. Blood Purif 2008;26:6–11

321. KAYSEN GA, KOTANKO P, ZHU F, SARKAR SR, HEYMSFIELD SB, KUHLMANN MK, LEVIN NW. Estimation of adipose pools in hemodialysis patients from anthropometric measures.. J Ren Nutr. 2008 Nov;18(6):473-8.

322. KLEINERT J, KOTANKO P, SPADA M, PAGLIARDINI S, PASCHKE E, PAUL K, VOIGTLÄNDER T, WALLNER M, KRAMAR R, STUMMVOLL HK, SCHWARZ C, HORN S, HOLZER H, FÖDINGER M, SUNDER-PLASSMANN G. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria., . Transpl Int. 2009 Mar;22(3):287-92. doi: 10.1111/j.1432-2277.2008.00791.x. Epub 2008 Oct 24.

323. KOTANKO P, LEVIN NW, ZHU F. Current state of bioimpedance technologies in dialysis.. Nephrol Dial Transplant.2008 Mar;23(3):808-12.

324. KOTANKO P, THIJSSEN S, LEVIN NW. Association between erythropoietin responsiveness and body composition in dialysis patients.. Bloof Purification 2008; 26 (1):82-9,

325. KRUSE A, UEHLINGER DE, GOTCH F, KOTANKO P, LEVIN NW. Red blood cell lifespan, erythropoiesis and hempglobin control.. Contrib Nephrol. 2008;161:247-54.

326. KUHLMANN MK, LEVIN NW. How common is malnutrition in ESRD? New approaches to diagnosis of malnutrition. Blood Purif. 2008;26(1):49-53

327. LACSON E JR, LAZARUS JM, PANLILIO R, GOTCH F. Comparison of hemodialysis blood access flow rates using online measurement of conductivity dialysance and ultrasound dilution.. Am J Kidney Dis. 2008 Jan;51(1):99-106

328. LACSON E JR, ROGUS J, TENG M, LAZARUS JM, HAKIM RM. The association of race with erythropoietin dose in patients on long-term hemodialysis. Am J Kidney Dis 2008 Dec; 52(6): 1104-14.,

329. NESRALLAH GE, SURI RS, MOIST RM, OFSTHUN NJ, HAKIM RM, MCDONALD, S, MARSHALL M, CARTER ST, RINDSAY RM. The international quotidian dialysis registry. Annual report 2008, Hemodialysis International, 2008: 12: 281-289.

330. PKUHLMANN MK, LEVIN NW. Potential Interplay between Nutrition and Inflammation in Dialysis Patients.. Contrib Nephrol. 2008;161:76-82.

331. QUNIBI W, MOUSTAFA M, MUENZ LR, HE DY, KESSLER PD, DIAZ-BUXO JA, BUDOFF M; CARE-2 INVESTIGATORS. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis. 2008 Jun;51(6):952-65. doi: 10.1053/j.ajkd.2008.02.298. Epub 2008 Apr 18.

332. QUNIBI W, MUENZ LR, DIAZ-BUXO JA. The CARE-2 study results: setting the record straight, . Nephrol Dial Transplant. 2008 Dec;23(12):4081-2; author reply 4082-3. doi: 10.1093/ndt/gfn520. Epub 2008 Sep 26. No abstract availabl

333. RAIMANN J, LIU L, ULLOA D, KOTANKO P, LEVIN NW. Consequences of overhydration and the need for dry weight assessment.. Contrib Nephrol. 2008;161:99-107.

334. RAYMOND M. Reducing early mortality in hemodialysis patients. Nephrology and Hypertension 2008, 17:595–599

335. RICHTER A, KUHLMANN MK, SEIBERT E, KOTANKO P, , LEVIN NW, HANDELMAN GJ. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients.. Nephrol Dial Transplant. Nephrol Dial Transplant (2008) 23: 2058–2063

336. RONCO C, LEVIN NW. Dialysis: Advances in Chronic Kidney Disease.. Preface.Blood Purif.2008;26(1):5. Epub 2008 Jan 10.

337. THIJSSEN S, KITZLER TM, LEVIN NW. Salt: its role in chronic kidney disease. J Ren Nutr. 2008 Jan;18(1): 18-26.

338. THIJSSEN S, KOTANKO P, LEVIN NW. What are the potential solutions for the problems with current methods for quantifying hemodialysis?: volume and large/protein-bound toxins.. Semin Dial. 2008 Sep-Oct;21(5):409-11.

339. TTENTORI F, ALBERT JM, YOUNG EW, BLAYNEY MJ, ROBINSON BM, PISONI RL, AKIBA T, GREENWOOD RN, KIMATA N, LEVIN NW, PIERA LM, SARAN R, WOLFE RA, PORT FK. The survival advantage for hemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.. Nephrol Dial Transplant. 2008 Nov 21.

340. ZHU F, KUHLMANN MK, KOTANKO P, SEIBERT E, LEONARD EF, LEVIN NW. A method for the estimation of hydration state during hemodialysis using a calf bioimpedance technique.. Physiol Meas. 2008 Jun;29(6):S503-16.

341. . ZHU F, LEONARD EF, LEVIN NW. Extracellular fluid redistribution during hemodialysis:bioimpedance measurement and model.. Physiol Meas. 2008 Jun;29(6)S491-501

342. ZITT E, NEYER U, MEUSBURGER E, TIEFENTHALER M, KOTANKO P, MAYER G, ROSENKRANZ AR. Effect of dialysate temperature and diabetes on autonomic cardiovascular regulation during hemodialysis. Kidney Blood Press Res. 2008;31(4):217-25. doi: 10.1159/000141926. Epub 2008 Jun 28.

2007

343. , LACSON EJR, LAZARUS JM, HIMMELFARB J, IKIZLER TA, HAKIM RM:. Balancing Fistula First with Catheters Last,, . Am J Kidney Dis., 2007 Sep; 50(3): pp. 395-95

344. . GARG AX, GREENE T, LEVIN NW. A Well-Conducted Randomized Trial That Establishes No Benefit of Therapy is an Important Medical Advance. Nephrol Dial Transplant. 2007 Oct 31.

345. B.J. LIPPS, C. RONCO, N.W. LEVIN, P. Celebrating Dr. Gotch's 80th Birthday. Int J Artif Organs. 2007 Nov;30(11):951-2

346. BONADIO TL, DIAZ-BUXO JA. Definition of recurrent peritonitis. Perit Dial Int. 2007 Nov-Dec;27(6):716-8; author reply 718-9. No abstract available.

347. D. SCHNEDITZ, I. BACHLER, L.M. ROSALES, E. WIJNEN, N.W. Access flow measurement by indicator dilution without indicator injection:effect of switch location.. Int J Artif Organs. 2007 Nov;30(11):980-6

348. DIAZ-BUXO JA. Peritoneal dialysis solutions low in glucose degradation products: clinical experience and outcomes., . Adv Perit Dial. 2007;23:132-4. Review

349. DIAZ-BUXO JA. Prescription writing: CAPD and PD plus. Clin Nephrol. 2007 Dec;68(6):349-53. Review.

350. DIAZ-BUXO JA, CRAWFORD-BONADIO TL. Major difficulties the US nephrologist faces in providing adequate dialysis.. Blood Purif. 2007;25(1):48-52. Epub 2006 Dec 14

351. EDUARDO LACSON, JR, MD, MPH, FASN,1 J. Comparison of Hemodialysis Blood Access Flow Rates Using Online Measurement of conductivity Dialysance and Ultrasound Dilution. Am J Kidney Dis 51:99-106. © 2007 by the National Kidney Foundation, Inc.

352. FRANKLIN W. MADDUX, MD, FACP, SHARASHCHANDRA SHETTY, PHD, MICHAEL DEL AGUILA, PHD, MICHAEL NELSON, PHARMD, AND BRIAN M. MURRAY, MD, FACP, FRCPI, ANN. Effect of Erythropoiesis Stimulating Agents on Healthcare Utilization and Costs in Subjects with Anemia of Chronic Kidney Disease Not Requiring Dialysis. Pharmacother., Nov 2007; 41: 1761 - 17.

353. HANDLEMAN G, KOTANKO P, LEVIN NW. Mechanisms of hypertension.. N.Engl J Med.2007 Aug 23;357(8):827-9.

354. HOENICH NA, LEVIN NW. Hemodialysis machines. Biomed Instrum Technol. 2007 May-Jun;41(3):215-8.

355. JOSE A. AGENTS THAT MODULATE PERITONEAL MEMBRANE. Peritoneal Dialysis International, Vol. 27, pp. 16–30

356. KITLZER TM, SERGEYEVA O, MORRIS A, SKRABAL F, KOTANKO P, LEVIN NW. Noninvasive measurement of cardiac output in hemodialysis patients task force monitor:a comparison with the Transonic System.. ASAIO J. 2007 Sept-Oct;53(5):561-5.

357. LACSON E JR, LAZARUS JM. The association of the sodium "setpoint" to interdialytic weight gain and blood pressure in hemodialysis patients. Semin Dial. 2007 Nov-Dec;20(6):510-7. Review.

358. LACSON E JR, LAZARUS JM. The association between blood pressure and mortality in ESRD-not different from the general population?, . Semin Dial. 2007 Nov-Dec;20(6):510-7. Review.

359. LACSON EJR, IKIZLER TA, LAZARUS JM, TENG M, HAKIM RM. Potential Impact of Nutritional Intervention on End-Stage Renal Disease Hospitalization, Death, and Treatment Costs,. Journal of Renal Nutrition, Vol 17, No 6 (November), 2007: pp 363-372

360. LAZARUS JM, HAKIM RM. Dialysis facility ownership and Epoetin dosing in hemodialysis patients: a dialysis provider’s perspective. Am J Kidney Dis, 2007 Sep; 30(3): pp. 366-70.

361. LEVIN NW, FISHBANE S. CANEDO FV, ZEIG S, NASSER GM, MORAN JE, VILLA G, BEYER U, OGUEY D, MAXIMA STUDY INVESTIGATORS. Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).. Lancet. 2007 Oct 20;370(9596):1415-21.

362. LEVIN NW, HANDLEMAN GJ, CORESH J, PORT FK, KAYSEN GA. Reverse epidemiology: a confusing, confounding, and inaccurate term. Semin Dial. 2007 Nov-Dec;20(6):586-92.

363. LOWRIE EG. The kinetic behaviors of urea and other marker molecules during hemodialysis.. Am J Kidney Dis. 2007 Aug;50(2):181-3. No abstract available.

364. OFSTHUN NJ, LAZARUS JM. Impact of the change in CMS billing rules for erythropoietin on hemoglobin outcomes in dialysis patients. Blood Purif. 2007;25(1):31-5. Epub 2006 Dec 12

365. P KOTANKO, N.W. The impact of visceral mass on survival in chronic hemodialysis patients.. Int J Artif Organs, 2007 Nov;30(11); 993-9

366. REBECCA L. WINGARD,* LARA B. PUPIM,†‡ MAHESH KRISHNAN,‡ AYUMI SHINTANI,† T. Early Intervention Improves Mortality and Hospitalization Rates in Incident Hemodialysis Patients. Clin J Am Soc Nephrol 2: 1170–1175, 2007. doi: 10.2215/CJN.04261206

367. SANDS JJ. Increasing AV fistulae and decreasing dialysis catheters: two aspects of improving patient outcomes. Blood Purif. 2007;25(1):99-102. Epub 2006 Dec 14.

368. SANDS JJ. Vascular access 2007. Urol Nefrol. 2007 Sep;59(3):237-49. Review

369. SARKAR SR, WYSTRYCHOWSKI G, ZHU F, USVYAT LA, KOTANKO P AND LEVIN NW:. Fluid dynamics during hemodialysis in relationship to sodium gradient between dialysate and plasma.. ASAIO J 53:339-342.2007

370. THIJSSEN S, WYSTRYCHOWSKI G, USVYAT L, KOTANKO P AND LEVIN NW:. Determinants of serum albumin concentration analyzed in a large cohort of patients on maintenance hemodialysis. J Ren Nutr 17:70-74.2007

371. WANG S, GERACI G, KUHLMANN MK, LEVIN NW, HANDLEMAN GJ. Chemical reactions of vitamin C with intravenous-iron formulations. Nephrol Dial Transplant. 2007 Oct 19.

372. WYSTRYCHOWSKI G, LEVIN NW. Dry weight: sine qua non of adequate dialysis. Adv Chronic Kidney Dis. 2007 Jul;14(3):e10-6.

2006

373. CHERTOW GM, KURELLA M, LOWRIE EG. The tortoise and hare on hemodialysis: does slow and steady win the race?, . Kidney Int. 2006 Jul;70(1):24-5. Epub 2006 Jun 7. Review

374. DIAZ-BUXO JA, CRAWFORD-BONADIO TL, ST PIERRE D, INGRAM KM. Establishing a successful home dialysis program. Blood Purif. 2006;24(1):22-7

375. DIAZ-BUXO JA, GOTLOIB L. Peritoneal dialysis solutions--at a crossroad. Minerva Urol Nefrol. 2006 Jun;58(2):145-60.

376. DIAZ-BUXO JA, LOREDO JP. Standard Kt/V: comparison of calculation methods. Artif Organs. 2006 Mar;30(3):178-85. Erratum in: Artif Organs. 2006 Jun;30(6):490.

377. EG LOWRIE1, Z LI1, NJ OFSTHUN1 AND JM LAZARUS1. Evaluating a new method to judge dialysis treatment using online measurements of ionic clearance. Kidney International (2006) 70, 211–217. doi:10.1038/sj.ki.5001507;

378. JEFFFREY J. Disease Management Improves End-Stage Renal Disease Outcomes. Blood Purif 2006;24:394–399

379. JOSE A. DIAZ-BUXO,1 H. Protecting the endothelium: A new focus for management of chronic kidney disease. Hemodialysis International 2006; 10: 42–48

380. JOSEPH PULLIAM, RAYMOND HAKIM, MICHAEL LAZARUS. Peritoneal Dialysis in Large Dialysis Chains. Peritoneal Dialysis International, Vol. 26, pp. 435–437

381. KENNEY RJ, PIERRATOS A, PULLIAM JP. Dialyzing at home with the 2008K. Nephrol News Issues. 2006 Oct;20(11):62, 64.

382. LACSON E JR, LAZARUS JM. Dialyzer best practice: single use or reuse?, . Semin Dial. 2006 Mar-Apr;19(2):120-8.

383. LAZARUS JM, HAKIM RM. Translating Epoetin research into practice: the role of government and the use of scientific evidence. Nephrol News Issues, 2006 Dec: 20(13); 12,22.

384. LI Z, LACSON E JR, LOWRIE EG, OFSTHUN NJ, KUHLMANN MK, LAZARUS JM, LEVIN NW. The epidemiology of systolic blood pressure and death risk in hemodialysis patients.,. Am J Kidney Dis. 2006 Oct;48(4):606-15

385. LOWRIE EG, OFSTHUN NJ. To reuse or not to reuse: a tale of 2 studies. Am J Kidney Dis. 2006 Feb;47(2):372; author reply 372-3. No abstract available.

386. R MISHLER1, JJ SANDS2, NJ OFSTHUN2, M TENG2, D SCHON1 AND JM LAZARUS. Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments. Kidney International (2006) 69, 393–398

387. SANDS JJ, ETHEREDGE GD, SHANKAR A, GRAFF J, LOEPER J, MCKENDRY M, FARRELL R. Predicting hospitalization and mortality in end-stage renal disease (ESRD) patients using an Index of Coexisting Disease (ICED)-based risk stratification model. Dis Manag. 2006 Aug;9(4):224-35.

388. SR SARKAR1, MK KUHLMANN1, P KOTANKO1, F ZHU1, SB HEYMSFIELD2, J WANG2, IS MEISELS3, FA GOTCH GA KAYSEN, NW LEVIN. Metabolic consequences of body size and body composition in hemodialysis patients. Kidney International (2006) 70, 1832–1839

389. WILLIAMS ME, LACSON E JR, TENG M, OFSTHUN N, LAZARUS JM. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int. 2006 Oct;70(8):1503-9. Epub 2006 Aug 30.

2005

390. , LOWRIE EG, LI Z, OFSTHUN N, LAZARUS JM. Reprocessing dialysers for multiple uses: recent analysis of death risks for patients. Nephro Dial Transplant 2004 Nov;19(11):2823-30. Epub 2004 Aug 17.

391. CHRISTIAN SCHLAEPER JOSÉ A. Home Hemodialysis and Remote Monitoring: Current Technology Requirements and Capabilities. Blood Purif 2005;23:18–22

392. COLLINS AJ, BRENNER RM, OFMAN JJ, CHI EM, STUCCIO-WHITE N, KRISHNAN M, SOLID C, OFSTHUN NJ, LAZARUS JM. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes. Am J Kidney Dis. 2005 Sep;46(3):481-8

393. DIAZ-BUXO JA. Bicarbonate solutions: update. Adv Perit Dial. 2005;21:115-9., Adv Perit Dial. 2005;21:115-9.

394. DIAZ-BUXO JA, CRAWFORD-BONADIO TL. Impact of peritoneal dialysis technology on patients, . Adv Perit Dial. 2005;21:112-4.

395. GLENN M. CHERTOW, D. JORDI GOLDSTEIN-FUCHS, J. MICHAEL LAZARUS, AND GEORGE A. Prealbumin, mortality, and cause-specific hospitalization in Hemodialysis Patients. Kidney International, Vol. 68 (2005), pp. 2794–2800

396. JOSE A. ACCESS AND CONTINUOUS FLOW PERITONEAL DIALYSIS. Perit Dial Int 2005; 25(S3):S102–S104

397. JOSE A. Beyond thrice-weekly hemodialysis. Hemodialysis International 2005; 9: 309–313

398. LACSON E, TENG M, ONG J, VIENNEAU L, OFSTHUN N, LAZARUS JM. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int. 2005 Oct;9(4):367-75

399. LAZARUS JM, HAKIM RM, MADDUX FW, AMEDIA CA JR. The emperor has no clothes (but has a catheter): a perspective on the state of chronic kidney disease care. Nephrol News Issues, 2005 Nov; 19(12): 45-6, 48.

400. LOWRIE EG, LI Z, OFSTHUN N, LAZARUS JM. The online measurement of hemodialysis dose (Kt): clinical outcome as a function of body surface area. Kidney Int. 2005 Sep;68(3):1344-54.

401. REDDAN DN, SZCZECH LA, HASSELBLAD V, LOWRIE EG, LINDSAY RM, HIMMELFARB J, TOTO RD, STIVELMAN J, WINCHESTER JF, ZILLMAN LA, CALIFF RM, OWEN WF JR. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial, . J Am Soc Nephrol. 2005 Jul;16(7):2162-9. Epub 2005 Jun 1.

402. SANDS JJ. Vascular access monitoring improves outcomes. Blood Purif. 2005;23(1):45-9